{
    "medicine_id": "de0eb7d9f6e4311baf7623ec008fa398393bf681",
    "platform_id": "DB01240",
    "metadata": {
        "name": "Caripul 0 5 MG Powder for solution",
        "composition": "0 5 MG Epoprostenol",
        "clinical_particulars": {
            "therapeutic_indications": "For the long term intravenous treatment of primary pulmonary hypertension and pulmonary hypertension associated with the scleroderma spectrum of disease in NYHA Class III and Class IV patients who do not respond adequately to conventional therapy",
            "contraindications": {
                "disease": "Symptoms of overdose are extensions of its dose limiting pharmacologic effects and include flushing headache hypotension nausea vomiting and diarrhea Most events were self limiting and resolved with reduction or withholding of epoprostenol Single intravenous doses at 10 and 50 mg kg 2703 and 27 027 times the recommended acute phase human dose based on body surface area were lethal to mice and rats respectively Symptoms of acute toxicity were hypoactivity ataxia loss of righting reflex deep slow breathing and hypothermia",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "Epoprostenol has two major pharmacological actions 1 direct vasodilation of pulmonary and systemic arterial vascular beds and 2 inhibition of platelet aggregation In animals the vasodilatory effects reduce right and left ventricular afterload and increase cardiac output and stroke volume The effect of epoprostenol on heart rate in animals varies with dose At low doses there is vagally mediated brudycardia but at higher doses epoprostenol causes reflex tachycardia in response to direct vasodilation and hypotension No major effects on cardiac conduction have been observed Additional pharmacologic effects of epoprostenol in animals include bronchodilation inhibition of gastric acid secretion and decreased gastric emptying No available chemical assay is sufficiently sensitive and specific to assess the in vivo human pharmacokinetics of epoprostenol",
                "excipients": "NA",
                "incompatibilities": [
                    {
                        "drugbank-id": "DB06605",
                        "description": "Apixaban may increase the anticoagulant activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB06695",
                        "description": "Dabigatran etexilate may increase the anticoagulant activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB01254",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Dasatinib is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB01609",
                        "description": "The risk or severity of gastrointestinal bleeding can be increased when Epoprostenol is combined with Deferasirox"
                    },
                    {
                        "drugbank-id": "DB09075",
                        "description": "The risk or severity of bleeding can be increased when Edoxaban is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB09053",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Ibrutinib is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB06228",
                        "description": "Epoprostenol may increase the anticoagulant activities of Rivaroxaban"
                    },
                    {
                        "drugbank-id": "DB06206",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Epoprostenol is combined with Sugammadex"
                    },
                    {
                        "drugbank-id": "DB09070",
                        "description": "Tibolone may increase the anticoagulant activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00013",
                        "description": "Urokinase may increase the anticoagulant activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB09030",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Vorapaxar is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00476",
                        "description": "The risk or severity of orthostatic hypotension and syncope can be increased when Epoprostenol is combined with Duloxetine"
                    },
                    {
                        "drugbank-id": "DB01235",
                        "description": "The risk or severity of hypotension and orthostatic hypotension can be increased when Epoprostenol is combined with Levodopa"
                    },
                    {
                        "drugbank-id": "DB00734",
                        "description": "Epoprostenol may increase the hypotensive activities of Risperidone"
                    },
                    {
                        "drugbank-id": "DB01586",
                        "description": "The risk or severity of adverse effects can be increased when Epoprostenol is combined with Ursodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB02123",
                        "description": "The risk or severity of adverse effects can be increased when Epoprostenol is combined with Glycochenodeoxycholic Acid"
                    },
                    {
                        "drugbank-id": "DB02659",
                        "description": "The risk or severity of adverse effects can be increased when Epoprostenol is combined with Cholic Acid"
                    },
                    {
                        "drugbank-id": "DB02691",
                        "description": "The risk or severity of adverse effects can be increased when Epoprostenol is combined with Glycocholic acid"
                    },
                    {
                        "drugbank-id": "DB03619",
                        "description": "The risk or severity of adverse effects can be increased when Epoprostenol is combined with Deoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB04348",
                        "description": "The risk or severity of adverse effects can be increased when Epoprostenol is combined with Taurocholic acid"
                    },
                    {
                        "drugbank-id": "DB05990",
                        "description": "The risk or severity of adverse effects can be increased when Epoprostenol is combined with Obeticholic acid"
                    },
                    {
                        "drugbank-id": "DB06777",
                        "description": "The risk or severity of adverse effects can be increased when Epoprostenol is combined with Chenodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB08833",
                        "description": "The risk or severity of adverse effects can be increased when Epoprostenol is combined with Taurochenodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB08834",
                        "description": "The risk or severity of adverse effects can be increased when Epoprostenol is combined with Tauroursodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB08857",
                        "description": "The risk or severity of adverse effects can be increased when Epoprostenol is combined with Bamet UD2"
                    },
                    {
                        "drugbank-id": "DB11622",
                        "description": "The risk or severity of adverse effects can be increased when Epoprostenol is combined with Dehydrocholic acid"
                    },
                    {
                        "drugbank-id": "DB11789",
                        "description": "The risk or severity of adverse effects can be increased when Epoprostenol is combined with Hyodeoxycholic Acid"
                    },
                    {
                        "drugbank-id": "DB01296",
                        "description": "Glucosamine may increase the antiplatelet activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00078",
                        "description": "The risk or severity of adverse effects can be increased when Epoprostenol is combined with Ibritumomab tiuxetan"
                    },
                    {
                        "drugbank-id": "DB08935",
                        "description": "The risk or severity of adverse effects can be increased when Epoprostenol is combined with Obinutuzumab"
                    },
                    {
                        "drugbank-id": "DB00932",
                        "description": "Tipranavir may increase the antiplatelet activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00163",
                        "description": "Vitamin E may increase the antiplatelet activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00346",
                        "description": "Alfuzosin may increase the hypotensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB01143",
                        "description": "Epoprostenol may increase the hypotensive activities of Amifostine"
                    },
                    {
                        "drugbank-id": "DB01119",
                        "description": "Diazoxide may increase the hypotensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00422",
                        "description": "Methylphenidate may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB06701",
                        "description": "Dexmethylphenidate may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00073",
                        "description": "Epoprostenol may increase the hypotensive activities of Rituximab"
                    },
                    {
                        "drugbank-id": "DB00191",
                        "description": "Phentermine may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00211",
                        "description": "Midodrine may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00216",
                        "description": "Eletriptan may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00221",
                        "description": "Isoetharine may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00247",
                        "description": "Methysergide may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00248",
                        "description": "Cabergoline may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00315",
                        "description": "Zolmitriptan may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00320",
                        "description": "Dihydroergotamine may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00344",
                        "description": "Protriptyline may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00353",
                        "description": "Methylergometrine may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00368",
                        "description": "Norepinephrine may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00370",
                        "description": "Mirtazapine may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00388",
                        "description": "Phenylephrine may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00397",
                        "description": "Phenylpropanolamine may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00420",
                        "description": "Promazine may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00450",
                        "description": "Droperidol may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00540",
                        "description": "Nortriptyline may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00543",
                        "description": "Amoxapine may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00561",
                        "description": "Doxapram may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00572",
                        "description": "Atropine may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00589",
                        "description": "Lisuride may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00610",
                        "description": "Metaraminol may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00668",
                        "description": "Epinephrine may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00696",
                        "description": "Ergotamine may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00699",
                        "description": "Nicergoline may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00723",
                        "description": "Methoxamine may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00726",
                        "description": "Trimipramine may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00777",
                        "description": "Propiomazine may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00802",
                        "description": "Alfentanil may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00816",
                        "description": "Orciprenaline may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00830",
                        "description": "Phenmetrazine may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00831",
                        "description": "Trifluoperazine may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00852",
                        "description": "Pseudoephedrine may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00865",
                        "description": "Benzphetamine may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00867",
                        "description": "Ritodrine may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00875",
                        "description": "Flupentixol may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00901",
                        "description": "Bitolterol may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00935",
                        "description": "Oxymetazoline may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00937",
                        "description": "Diethylpropion may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00938",
                        "description": "Salmeterol may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00952",
                        "description": "Naratriptan may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00983",
                        "description": "Formoterol may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00998",
                        "description": "Frovatriptan may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB01028",
                        "description": "Methoxyflurane may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB01049",
                        "description": "Ergoloid mesylate may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB01064",
                        "description": "Isoprenaline may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB01102",
                        "description": "Arbutamine may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB01126",
                        "description": "Dutasteride may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB01182",
                        "description": "Propafenone may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB01186",
                        "description": "Pergolide may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB01216",
                        "description": "Finasteride may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB01253",
                        "description": "Ergometrine may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB01255",
                        "description": "Lisdexamfetamine may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB01288",
                        "description": "Fenoterol may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB01291",
                        "description": "Pirbuterol may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB01363",
                        "description": "Ephedra sinica root may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB01364",
                        "description": "Ephedrine may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB01365",
                        "description": "Mephentermine may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB01366",
                        "description": "Procaterol may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB01392",
                        "description": "Yohimbine may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB01403",
                        "description": "Methotrimeprazine may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB01407",
                        "description": "Clenbuterol may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB01408",
                        "description": "Bambuterol may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB01442",
                        "description": "MMDA may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB01454",
                        "description": "Midomafetamine may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB01467",
                        "description": "2 5 Dimethoxy 4 ethylamphetamine may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB01472",
                        "description": "4 Methoxyamphetamine may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB01484",
                        "description": "4 Bromo 2 5 dimethoxyamphetamine may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB01509",
                        "description": "Tenamfetamine may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB01556",
                        "description": "Chlorphentermine may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB01576",
                        "description": "Dextroamphetamine may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB01579",
                        "description": "Phendimetrazine may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB01591",
                        "description": "Solifenacin may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB01608",
                        "description": "Periciazine may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB01614",
                        "description": "Acepromazine may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB01622",
                        "description": "Thioproperazine may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB01624",
                        "description": "Zuclopenthixol may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB02032",
                        "description": "Epicaptopril may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB04581",
                        "description": "1 benzylimidazole may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB04829",
                        "description": "Lysergic acid diethylamide may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB04836",
                        "description": "Amineptine may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB04855",
                        "description": "Dronedarone may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB04908",
                        "description": "Flibanserin may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB04946",
                        "description": "Iloperidone may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB05039",
                        "description": "Indacaterol may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB05395",
                        "description": "Amibegron may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB05562",
                        "description": "Naluzotan may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB06016",
                        "description": "Cariprazine may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB06148",
                        "description": "Mianserin may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB06152",
                        "description": "Nylidrin may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB06153",
                        "description": "Pizotifen may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB06190",
                        "description": "Solabegron may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB06216",
                        "description": "Asenapine may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB06678",
                        "description": "Esmirtazapine may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB06684",
                        "description": "Vilazodone may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB06690",
                        "description": "Nitrous oxide may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB06694",
                        "description": "Xylometazoline may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB06706",
                        "description": "Isometheptene may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB06707",
                        "description": "Levonordefrin may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB06711",
                        "description": "Naphazoline may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB06763",
                        "description": "Saralasin may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB06764",
                        "description": "Tetryzoline may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB08810",
                        "description": "Cinitapride may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB08815",
                        "description": "Lurasidone may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB08841",
                        "description": "Tyramine may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB08925",
                        "description": "Adrafinil may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB08954",
                        "description": "Ifenprodil may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB08957",
                        "description": "Hexoprenaline may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB08985",
                        "description": "Etilefrine may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB09016",
                        "description": "Butriptyline may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB09061",
                        "description": "Cannabidiol may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB09080",
                        "description": "Olodaterol may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB09128",
                        "description": "Brexpiprazole may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB09167",
                        "description": "Dosulepin may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB09202",
                        "description": "Cirazoline may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB09203",
                        "description": "Synephrine may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB09289",
                        "description": "Tianeptine may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB09307",
                        "description": "Oxaprotiline may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB09480",
                        "description": "Iofetamine I 123 may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB11124",
                        "description": "Racepinephrine may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB11273",
                        "description": "Dihydroergocornine may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB11373",
                        "description": "Amitraz may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB11428",
                        "description": "Medetomidine may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB11477",
                        "description": "Xylazine may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB11481",
                        "description": "Atipamezole may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB11541",
                        "description": "Ractopamine may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB11543",
                        "description": "Romifidine may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB11556",
                        "description": "Detomidine may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB11755",
                        "description": "Tetrahydrocannabivarin may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB11785",
                        "description": "Anisodamine may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB11871",
                        "description": "PF 00610355 may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB12080",
                        "description": "Ritobegron may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB12100",
                        "description": "Abediterol may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB12248",
                        "description": "Tulobuterol may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB12313",
                        "description": "Dopexamine may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB12361",
                        "description": "Piclozotan may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB12371",
                        "description": "Siponimod may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB12551",
                        "description": "Idazoxan may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB12779",
                        "description": "Higenamine may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB12846",
                        "description": "Reproterol may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB12927",
                        "description": "Theodrenaline may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB12930",
                        "description": "Opipramol may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB13064",
                        "description": "Tramazoline may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB13108",
                        "description": "Mephedrone may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB13114",
                        "description": "Amitriptylinoxide may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB13225",
                        "description": "Dibenzepin may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB13246",
                        "description": "Quinupramine may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB13251",
                        "description": "Octopamine may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB13323",
                        "description": "Trichloroethylene may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB13341",
                        "description": "Fenozolone may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB13345",
                        "description": "Dihydroergocristine may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB13378",
                        "description": "Norfenefrine may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB13384",
                        "description": "Melitracen may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB13385",
                        "description": "Dihydroergocryptine may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB13398",
                        "description": "Oxyfedrine may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB13399",
                        "description": "Terguride may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB13411",
                        "description": "Lofepramine may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB13453",
                        "description": "Xenon may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB13496",
                        "description": "Iprindole may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB13520",
                        "description": "Metergoline may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB13559",
                        "description": "Rimiterol may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB13598",
                        "description": "Diethyl ether may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB13624",
                        "description": "Methoxyphenamine may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB13692",
                        "description": "Tretoquinol may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB13703",
                        "description": "Gepefrine may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB13777",
                        "description": "Prenalterol may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB13781",
                        "description": "Xamoterol may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB13782",
                        "description": "Imipramine oxide may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB13852",
                        "description": "Mefenorex may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB13917",
                        "description": "Deoxyepinephrine may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB13940",
                        "description": "2 5 Dimethoxy 4 ethylthioamphetamine may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB14010",
                        "description": "5 methoxy N N dimethyltryptamine may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB14231",
                        "description": "Quinoline Yellow WS may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00679",
                        "description": "Thioridazine may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00708",
                        "description": "Sufentanil may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00753",
                        "description": "Isoflurane may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00818",
                        "description": "Propofol may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00899",
                        "description": "Remifentanil may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB01159",
                        "description": "Halothane may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB01189",
                        "description": "Desflurane may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB01200",
                        "description": "Bromocriptine may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB05271",
                        "description": "Rotigotine may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB08941",
                        "description": "Isoxsuprine may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00813",
                        "description": "Fentanyl may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB01151",
                        "description": "Desipramine may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB01242",
                        "description": "Clomipramine may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB08996",
                        "description": "Dimetacrine may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB15685",
                        "description": "Selpercatinib may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB15965",
                        "description": "Naxitamab may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB01381",
                        "description": "The therapeutic efficacy of Epoprostenol can be increased when used in combination with Ginkgo biloba"
                    },
                    {
                        "drugbank-id": "DB01181",
                        "description": "The risk or severity of bleeding can be increased when Ifosfamide is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00468",
                        "description": "The therapeutic efficacy of Epoprostenol can be increased when used in combination with Quinine"
                    },
                    {
                        "drugbank-id": "DB00908",
                        "description": "The therapeutic efficacy of Epoprostenol can be increased when used in combination with Quinidine"
                    },
                    {
                        "drugbank-id": "DB00675",
                        "description": "The risk or severity of bleeding can be increased when Tamoxifen is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00539",
                        "description": "The risk or severity of bleeding can be increased when Toremifene is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00806",
                        "description": "The therapeutic efficacy of Epoprostenol can be increased when used in combination with Pentoxifylline"
                    },
                    {
                        "drugbank-id": "DB00686",
                        "description": "The risk or severity of adverse effects can be increased when Pentosan polysulfate is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00583",
                        "description": "The therapeutic efficacy of Epoprostenol can be increased when used in combination with Levocarnitine"
                    },
                    {
                        "drugbank-id": "DB09220",
                        "description": "Nicorandil may increase the hypotensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB09282",
                        "description": "Molsidomine may increase the hypotensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00255",
                        "description": "Diethylstilbestrol may decrease the anticoagulant activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00269",
                        "description": "Chlorotrianisene may decrease the anticoagulant activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00286",
                        "description": "Conjugated estrogens may decrease the anticoagulant activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00783",
                        "description": "Estradiol may decrease the anticoagulant activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00977",
                        "description": "Ethinylestradiol may decrease the anticoagulant activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB01357",
                        "description": "Mestranol may decrease the anticoagulant activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB04574",
                        "description": "Estrone sulfate may decrease the anticoagulant activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB04575",
                        "description": "Quinestrol may decrease the anticoagulant activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB07931",
                        "description": "Hexestrol may decrease the anticoagulant activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB09317",
                        "description": "Synthetic Conjugated Estrogens A may decrease the anticoagulant activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB09318",
                        "description": "Synthetic Conjugated Estrogens B may decrease the anticoagulant activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB09369",
                        "description": "Polyestradiol phosphate may decrease the anticoagulant activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB09381",
                        "description": "Esterified estrogens may decrease the anticoagulant activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB11478",
                        "description": "Zeranol may decrease the anticoagulant activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB11674",
                        "description": "Equol may decrease the anticoagulant activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB13143",
                        "description": "Methallenestril may decrease the anticoagulant activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB13386",
                        "description": "Epimestrol may decrease the anticoagulant activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB13418",
                        "description": "Moxestrol may decrease the anticoagulant activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB13952",
                        "description": "Estradiol acetate may decrease the anticoagulant activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB13953",
                        "description": "Estradiol benzoate may decrease the anticoagulant activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB13954",
                        "description": "Estradiol cypionate may decrease the anticoagulant activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB13956",
                        "description": "Estradiol valerate may decrease the anticoagulant activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB15334",
                        "description": "Biochanin A may decrease the anticoagulant activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB15335",
                        "description": "Formononetin may decrease the anticoagulant activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00655",
                        "description": "Estrone may decrease the anticoagulant activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB04573",
                        "description": "Estriol may decrease the anticoagulant activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB09211",
                        "description": "The risk or severity of adverse effects can be increased when Limaprost is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00159",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Icosapent is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00244",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Mesalazine is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00328",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Indomethacin is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00461",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Nabumetone is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00465",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Ketorolac is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00469",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Tenoxicam is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00482",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Celecoxib is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00500",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Tolmetin is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00533",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Rofecoxib is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00554",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Piroxicam is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00573",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Fenoprofen is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00580",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Valdecoxib is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00586",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Diclofenac is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00605",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Sulindac is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00712",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Flurbiprofen is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00749",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Etodolac is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00784",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Mefenamic acid is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00788",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Naproxen is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00795",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Sulfasalazine is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00812",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Phenylbutazone is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00814",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Meloxicam is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00821",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Carprofen is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00861",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Diflunisal is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00936",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Salicylic acid is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00939",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Meclofenamic acid is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00991",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Oxaprozin is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB01009",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Ketoprofen is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB01014",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Balsalazide is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB01250",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Olsalazine is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB01283",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Lumiracoxib is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB01397",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Magnesium salicylate is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB01399",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Salsalate is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB01401",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Choline magnesium trisalicylate is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB01419",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Antrafenine is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB01424",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Aminophenazone is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB01435",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Antipyrine is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB01600",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Tiaprofenic acid is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB01628",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Etoricoxib is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB02224",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Taxifolin is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB03585",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Oxyphenbutazone is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB04725",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Licofelone is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB04812",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Benoxaprofen is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB04817",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Metamizole is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB04828",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Zomepirac is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB05095",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Cimicoxib is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB06725",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Lornoxicam is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB06736",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Aceclofenac is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB06737",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Zaltoprofen is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB07402",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Azapropazone is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB08439",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Parecoxib is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB08797",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Salicylamide is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB08940",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Kebuzone is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB08942",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Isoxicam is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB08951",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Indoprofen is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB08955",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Ibuproxam is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB08976",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Floctafenine is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB08981",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Fenbufen is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB08984",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Etofenamate is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB08991",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Epirizole is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB09084",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Benzydamine is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB09214",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Dexketoprofen is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB09215",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Droxicam is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB09216",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Tolfenamic acid is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB09217",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Firocoxib is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB09218",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Clonixin is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB09285",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Morniflumate is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB09288",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Propacetamol is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB09295",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Talniflumate is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB11455",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Robenacoxib is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB11466",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Tepoxalin is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB11518",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Flunixin is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB12399",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Polmacoxib is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB12610",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Ebselen is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB13001",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Tinoridine is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB13167",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Alclofenac is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB13217",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Fentiazac is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB13232",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Suxibuzone is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB13286",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Bumadizone is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB13314",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Alminoprofen is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB13371",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Difenpiramide is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB13407",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Nifenazone is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB13432",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Lonazolac is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB13481",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Tenidap is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB13524",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Propyphenazone is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB13527",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Proglumetacin is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB13538",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Guacetisal is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB13544",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Ethenzamide is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB13612",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Carbaspirin calcium is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB13629",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Mofebutazone is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB13649",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Proquazone is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB13657",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Benorilate is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB13722",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Pirprofen is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB13860",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Imidazole salicylate is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB14059",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when SC 236 is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB14060",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when NS 398 is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB14938",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Flurbiprofen axetil is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB09212",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Loxoprofen is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB04865",
                        "description": "The risk or severity of bleeding can be increased when Epoprostenol is combined with Omacetaxine mepesuccinate"
                    },
                    {
                        "drugbank-id": "DB00048",
                        "description": "The risk or severity of adverse effects can be increased when Epoprostenol is combined with Collagenase clostridium histolyticum"
                    },
                    {
                        "drugbank-id": "DB11133",
                        "description": "Omega 3 fatty acids may increase the antiplatelet activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00081",
                        "description": "The risk or severity of adverse effects can be increased when Epoprostenol is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB00287",
                        "description": "Travoprost may increase the hypotensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00521",
                        "description": "Carteolol may increase the hypotensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00869",
                        "description": "Dorzolamide may increase the hypotensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00905",
                        "description": "Bimatoprost may increase the hypotensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB01214",
                        "description": "Metipranolol may increase the hypotensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB06826",
                        "description": "Epoprostenol may increase the hypotensive activities of Unoprostone"
                    },
                    {
                        "drugbank-id": "DB00484",
                        "description": "Brimonidine may increase the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00235",
                        "description": "Milrinone may increase the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00862",
                        "description": "Vardenafil may increase the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB06237",
                        "description": "Avanafil may increase the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB06267",
                        "description": "Udenafil may increase the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB09273",
                        "description": "Doxofylline may increase the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB11792",
                        "description": "Mirodenafil may increase the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB12010",
                        "description": "Fostamatinib may increase the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00820",
                        "description": "Tadalafil may increase the hypotensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00374",
                        "description": "Treprostinil may increase the hypotensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00177",
                        "description": "Epoprostenol may increase the hypotensive activities of Valsartan"
                    },
                    {
                        "drugbank-id": "DB00178",
                        "description": "Epoprostenol may increase the hypotensive activities of Ramipril"
                    },
                    {
                        "drugbank-id": "DB00187",
                        "description": "Epoprostenol may increase the hypotensive activities of Esmolol"
                    },
                    {
                        "drugbank-id": "DB00195",
                        "description": "Epoprostenol may increase the hypotensive activities of Betaxolol"
                    },
                    {
                        "drugbank-id": "DB00206",
                        "description": "Epoprostenol may increase the hypotensive activities of Reserpine"
                    },
                    {
                        "drugbank-id": "DB00212",
                        "description": "Epoprostenol may increase the hypotensive activities of Remikiren"
                    },
                    {
                        "drugbank-id": "DB00214",
                        "description": "Epoprostenol may increase the hypotensive activities of Torasemide"
                    },
                    {
                        "drugbank-id": "DB00217",
                        "description": "Epoprostenol may increase the hypotensive activities of Bethanidine"
                    },
                    {
                        "drugbank-id": "DB00226",
                        "description": "Epoprostenol may increase the hypotensive activities of Guanadrel"
                    },
                    {
                        "drugbank-id": "DB00264",
                        "description": "Epoprostenol may increase the hypotensive activities of Metoprolol"
                    },
                    {
                        "drugbank-id": "DB00270",
                        "description": "Epoprostenol may increase the hypotensive activities of Isradipine"
                    },
                    {
                        "drugbank-id": "DB00275",
                        "description": "Epoprostenol may increase the hypotensive activities of Olmesartan"
                    },
                    {
                        "drugbank-id": "DB00310",
                        "description": "Epoprostenol may increase the hypotensive activities of Chlorthalidone"
                    },
                    {
                        "drugbank-id": "DB00325",
                        "description": "Epoprostenol may increase the hypotensive activities of Nitroprusside"
                    },
                    {
                        "drugbank-id": "DB00335",
                        "description": "Epoprostenol may increase the hypotensive activities of Atenolol"
                    },
                    {
                        "drugbank-id": "DB00343",
                        "description": "Epoprostenol may increase the hypotensive activities of Diltiazem"
                    },
                    {
                        "drugbank-id": "DB00350",
                        "description": "Epoprostenol may increase the hypotensive activities of Minoxidil"
                    },
                    {
                        "drugbank-id": "DB00373",
                        "description": "Epoprostenol may increase the hypotensive activities of Timolol"
                    },
                    {
                        "drugbank-id": "DB00381",
                        "description": "Epoprostenol may increase the hypotensive activities of Amlodipine"
                    },
                    {
                        "drugbank-id": "DB00393",
                        "description": "Epoprostenol may increase the hypotensive activities of Nimodipine"
                    },
                    {
                        "drugbank-id": "DB00401",
                        "description": "Epoprostenol may increase the hypotensive activities of Nisoldipine"
                    },
                    {
                        "drugbank-id": "DB00492",
                        "description": "Epoprostenol may increase the hypotensive activities of Fosinopril"
                    },
                    {
                        "drugbank-id": "DB00519",
                        "description": "Epoprostenol may increase the hypotensive activities of Trandolapril"
                    },
                    {
                        "drugbank-id": "DB00524",
                        "description": "Epoprostenol may increase the hypotensive activities of Metolazone"
                    },
                    {
                        "drugbank-id": "DB00528",
                        "description": "Epoprostenol may increase the hypotensive activities of Lercanidipine"
                    },
                    {
                        "drugbank-id": "DB00542",
                        "description": "Epoprostenol may increase the hypotensive activities of Benazepril"
                    },
                    {
                        "drugbank-id": "DB00559",
                        "description": "Epoprostenol may increase the hypotensive activities of Bosentan"
                    },
                    {
                        "drugbank-id": "DB00571",
                        "description": "Epoprostenol may increase the hypotensive activities of Propranolol"
                    },
                    {
                        "drugbank-id": "DB00584",
                        "description": "Epoprostenol may increase the hypotensive activities of Enalapril"
                    },
                    {
                        "drugbank-id": "DB00590",
                        "description": "Epoprostenol may increase the hypotensive activities of Doxazosin"
                    },
                    {
                        "drugbank-id": "DB00598",
                        "description": "Epoprostenol may increase the hypotensive activities of Labetalol"
                    },
                    {
                        "drugbank-id": "DB00612",
                        "description": "Epoprostenol may increase the hypotensive activities of Bisoprolol"
                    },
                    {
                        "drugbank-id": "DB00616",
                        "description": "Epoprostenol may increase the hypotensive activities of Candoxatril"
                    },
                    {
                        "drugbank-id": "DB00622",
                        "description": "Epoprostenol may increase the hypotensive activities of Nicardipine"
                    },
                    {
                        "drugbank-id": "DB00629",
                        "description": "Epoprostenol may increase the hypotensive activities of Guanabenz"
                    },
                    {
                        "drugbank-id": "DB00657",
                        "description": "Epoprostenol may increase the hypotensive activities of Mecamylamine"
                    },
                    {
                        "drugbank-id": "DB00678",
                        "description": "Epoprostenol may increase the hypotensive activities of Losartan"
                    },
                    {
                        "drugbank-id": "DB00691",
                        "description": "Epoprostenol may increase the hypotensive activities of Moexipril"
                    },
                    {
                        "drugbank-id": "DB00692",
                        "description": "Epoprostenol may increase the hypotensive activities of Phentolamine"
                    },
                    {
                        "drugbank-id": "DB00700",
                        "description": "Epoprostenol may increase the hypotensive activities of Eplerenone"
                    },
                    {
                        "drugbank-id": "DB00722",
                        "description": "Epoprostenol may increase the hypotensive activities of Lisinopril"
                    },
                    {
                        "drugbank-id": "DB00727",
                        "description": "Epoprostenol may increase the hypotensive activities of Nitroglycerin"
                    },
                    {
                        "drugbank-id": "DB00765",
                        "description": "Epoprostenol may increase the hypotensive activities of Metyrosine"
                    },
                    {
                        "drugbank-id": "DB00785",
                        "description": "Epoprostenol may increase the hypotensive activities of Cryptenamine"
                    },
                    {
                        "drugbank-id": "DB00790",
                        "description": "Epoprostenol may increase the hypotensive activities of Perindopril"
                    },
                    {
                        "drugbank-id": "DB00796",
                        "description": "Epoprostenol may increase the hypotensive activities of Candesartan cilexetil"
                    },
                    {
                        "drugbank-id": "DB00797",
                        "description": "Epoprostenol may increase the hypotensive activities of Tolazoline"
                    },
                    {
                        "drugbank-id": "DB00800",
                        "description": "Epoprostenol may increase the hypotensive activities of Fenoldopam"
                    },
                    {
                        "drugbank-id": "DB00866",
                        "description": "Epoprostenol may increase the hypotensive activities of Alprenolol"
                    },
                    {
                        "drugbank-id": "DB00876",
                        "description": "Epoprostenol may increase the hypotensive activities of Eprosartan"
                    },
                    {
                        "drugbank-id": "DB00881",
                        "description": "Epoprostenol may increase the hypotensive activities of Quinapril"
                    },
                    {
                        "drugbank-id": "DB00886",
                        "description": "Epoprostenol may increase the hypotensive activities of Omapatrilat"
                    },
                    {
                        "drugbank-id": "DB00925",
                        "description": "Epoprostenol may increase the hypotensive activities of Phenoxybenzamine"
                    },
                    {
                        "drugbank-id": "DB00960",
                        "description": "Epoprostenol may increase the hypotensive activities of Pindolol"
                    },
                    {
                        "drugbank-id": "DB00966",
                        "description": "Epoprostenol may increase the hypotensive activities of Telmisartan"
                    },
                    {
                        "drugbank-id": "DB00968",
                        "description": "Epoprostenol may increase the hypotensive activities of Methyldopa"
                    },
                    {
                        "drugbank-id": "DB01018",
                        "description": "Epoprostenol may increase the hypotensive activities of Guanfacine"
                    },
                    {
                        "drugbank-id": "DB01023",
                        "description": "Epoprostenol may increase the hypotensive activities of Felodipine"
                    },
                    {
                        "drugbank-id": "DB01029",
                        "description": "Epoprostenol may increase the hypotensive activities of Irbesartan"
                    },
                    {
                        "drugbank-id": "DB01054",
                        "description": "Epoprostenol may increase the hypotensive activities of Nitrendipine"
                    },
                    {
                        "drugbank-id": "DB01089",
                        "description": "Epoprostenol may increase the hypotensive activities of Deserpidine"
                    },
                    {
                        "drugbank-id": "DB01090",
                        "description": "Epoprostenol may increase the hypotensive activities of Pentolinium"
                    },
                    {
                        "drugbank-id": "DB01116",
                        "description": "Epoprostenol may increase the hypotensive activities of Trimethaphan"
                    },
                    {
                        "drugbank-id": "DB01136",
                        "description": "Epoprostenol may increase the hypotensive activities of Carvedilol"
                    },
                    {
                        "drugbank-id": "DB01158",
                        "description": "Epoprostenol may increase the hypotensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB01162",
                        "description": "Epoprostenol may increase the hypotensive activities of Terazosin"
                    },
                    {
                        "drugbank-id": "DB01170",
                        "description": "Epoprostenol may increase the hypotensive activities of Guanethidine"
                    },
                    {
                        "drugbank-id": "DB01180",
                        "description": "Epoprostenol may increase the hypotensive activities of Rescinnamine"
                    },
                    {
                        "drugbank-id": "DB01193",
                        "description": "Epoprostenol may increase the hypotensive activities of Acebutolol"
                    },
                    {
                        "drugbank-id": "DB01197",
                        "description": "Epoprostenol may increase the hypotensive activities of Captopril"
                    },
                    {
                        "drugbank-id": "DB01203",
                        "description": "Epoprostenol may increase the hypotensive activities of Nadolol"
                    },
                    {
                        "drugbank-id": "DB01244",
                        "description": "Epoprostenol may increase the hypotensive activities of Bepridil"
                    },
                    {
                        "drugbank-id": "DB01275",
                        "description": "Epoprostenol may increase the hypotensive activities of Hydralazine"
                    },
                    {
                        "drugbank-id": "DB01295",
                        "description": "Epoprostenol may increase the hypotensive activities of Bevantolol"
                    },
                    {
                        "drugbank-id": "DB01297",
                        "description": "Epoprostenol may increase the hypotensive activities of Practolol"
                    },
                    {
                        "drugbank-id": "DB01340",
                        "description": "Epoprostenol may increase the hypotensive activities of Cilazapril"
                    },
                    {
                        "drugbank-id": "DB01347",
                        "description": "Epoprostenol may increase the hypotensive activities of Saprisartan"
                    },
                    {
                        "drugbank-id": "DB01348",
                        "description": "Epoprostenol may increase the hypotensive activities of Spirapril"
                    },
                    {
                        "drugbank-id": "DB01359",
                        "description": "Epoprostenol may increase the hypotensive activities of Penbutolol"
                    },
                    {
                        "drugbank-id": "DB01388",
                        "description": "Epoprostenol may increase the hypotensive activities of Mibefradil"
                    },
                    {
                        "drugbank-id": "DB01580",
                        "description": "Epoprostenol may increase the hypotensive activities of Oxprenolol"
                    },
                    {
                        "drugbank-id": "DB01626",
                        "description": "Epoprostenol may increase the hypotensive activities of Pargyline"
                    },
                    {
                        "drugbank-id": "DB03322",
                        "description": "Epoprostenol may increase the hypotensive activities of Dexpropranolol"
                    },
                    {
                        "drugbank-id": "DB04831",
                        "description": "Epoprostenol may increase the hypotensive activities of Tienilic acid"
                    },
                    {
                        "drugbank-id": "DB04840",
                        "description": "Epoprostenol may increase the hypotensive activities of Debrisoquine"
                    },
                    {
                        "drugbank-id": "DB04846",
                        "description": "Epoprostenol may increase the hypotensive activities of Celiprolol"
                    },
                    {
                        "drugbank-id": "DB04861",
                        "description": "Epoprostenol may increase the hypotensive activities of Nebivolol"
                    },
                    {
                        "drugbank-id": "DB04948",
                        "description": "Epoprostenol may increase the hypotensive activities of Lofexidine"
                    },
                    {
                        "drugbank-id": "DB06268",
                        "description": "Epoprostenol may increase the hypotensive activities of Sitaxentan"
                    },
                    {
                        "drugbank-id": "DB06403",
                        "description": "Epoprostenol may increase the hypotensive activities of Ambrisentan"
                    },
                    {
                        "drugbank-id": "DB06445",
                        "description": "Epoprostenol may increase the hypotensive activities of Diethylnorspermine"
                    },
                    {
                        "drugbank-id": "DB06712",
                        "description": "Epoprostenol may increase the hypotensive activities of Nilvadipine"
                    },
                    {
                        "drugbank-id": "DB06762",
                        "description": "Epoprostenol may increase the hypotensive activities of Pinacidil"
                    },
                    {
                        "drugbank-id": "DB08808",
                        "description": "Epoprostenol may increase the hypotensive activities of Bupranolol"
                    },
                    {
                        "drugbank-id": "DB08836",
                        "description": "Epoprostenol may increase the hypotensive activities of Temocapril"
                    },
                    {
                        "drugbank-id": "DB08931",
                        "description": "Epoprostenol may increase the hypotensive activities of Riociguat"
                    },
                    {
                        "drugbank-id": "DB08932",
                        "description": "Epoprostenol may increase the hypotensive activities of Macitentan"
                    },
                    {
                        "drugbank-id": "DB08950",
                        "description": "Epoprostenol may increase the hypotensive activities of Indoramin"
                    },
                    {
                        "drugbank-id": "DB08952",
                        "description": "Epoprostenol may increase the hypotensive activities of Indenolol"
                    },
                    {
                        "drugbank-id": "DB08960",
                        "description": "Epoprostenol may increase the hypotensive activities of Hexamethonium"
                    },
                    {
                        "drugbank-id": "DB09026",
                        "description": "Epoprostenol may increase the hypotensive activities of Aliskiren"
                    },
                    {
                        "drugbank-id": "DB09206",
                        "description": "Epoprostenol may increase the hypotensive activities of Trimazosin"
                    },
                    {
                        "drugbank-id": "DB09235",
                        "description": "Epoprostenol may increase the hypotensive activities of Efonidipine"
                    },
                    {
                        "drugbank-id": "DB09238",
                        "description": "Epoprostenol may increase the hypotensive activities of Manidipine"
                    },
                    {
                        "drugbank-id": "DB09239",
                        "description": "Epoprostenol may increase the hypotensive activities of Niguldipine"
                    },
                    {
                        "drugbank-id": "DB09242",
                        "description": "Epoprostenol may increase the hypotensive activities of Moxonidine"
                    },
                    {
                        "drugbank-id": "DB09363",
                        "description": "Epoprostenol may increase the hypotensive activities of Rauwolfia serpentina root"
                    },
                    {
                        "drugbank-id": "DB09477",
                        "description": "Epoprostenol may increase the hypotensive activities of Enalaprilat"
                    },
                    {
                        "drugbank-id": "DB11362",
                        "description": "Epoprostenol may increase the hypotensive activities of Selexipag"
                    },
                    {
                        "drugbank-id": "DB11720",
                        "description": "Epoprostenol may increase the hypotensive activities of Angiotensin 1 7"
                    },
                    {
                        "drugbank-id": "DB11738",
                        "description": "Epoprostenol may increase the hypotensive activities of Rilmenidine"
                    },
                    {
                        "drugbank-id": "DB11770",
                        "description": "Epoprostenol may increase the hypotensive activities of Talinolol"
                    },
                    {
                        "drugbank-id": "DB11783",
                        "description": "Epoprostenol may increase the hypotensive activities of Imidapril"
                    },
                    {
                        "drugbank-id": "DB12054",
                        "description": "Epoprostenol may increase the hypotensive activities of BQ 123"
                    },
                    {
                        "drugbank-id": "DB12093",
                        "description": "Epoprostenol may increase the hypotensive activities of Tetrahydropalmatine"
                    },
                    {
                        "drugbank-id": "DB12212",
                        "description": "Epoprostenol may increase the hypotensive activities of Landiolol"
                    },
                    {
                        "drugbank-id": "DB12661",
                        "description": "Epoprostenol may increase the hypotensive activities of Urapidil"
                    },
                    {
                        "drugbank-id": "DB12766",
                        "description": "Epoprostenol may increase the hypotensive activities of Cicletanine"
                    },
                    {
                        "drugbank-id": "DB12945",
                        "description": "Epoprostenol may increase the hypotensive activities of Dihydralazine"
                    },
                    {
                        "drugbank-id": "DB13166",
                        "description": "Epoprostenol may increase the hypotensive activities of Zofenopril"
                    },
                    {
                        "drugbank-id": "DB13211",
                        "description": "Epoprostenol may increase the hypotensive activities of Guanoxan"
                    },
                    {
                        "drugbank-id": "DB13312",
                        "description": "Epoprostenol may increase the hypotensive activities of Delapril"
                    },
                    {
                        "drugbank-id": "DB13374",
                        "description": "Epoprostenol may increase the hypotensive activities of Vincamine"
                    },
                    {
                        "drugbank-id": "DB13410",
                        "description": "Epoprostenol may increase the hypotensive activities of Guanoxabenz"
                    },
                    {
                        "drugbank-id": "DB13429",
                        "description": "Epoprostenol may increase the hypotensive activities of Tolonidine"
                    },
                    {
                        "drugbank-id": "DB13435",
                        "description": "Epoprostenol may increase the hypotensive activities of Endralazine"
                    },
                    {
                        "drugbank-id": "DB13443",
                        "description": "Epoprostenol may increase the hypotensive activities of Esatenolol"
                    },
                    {
                        "drugbank-id": "DB13452",
                        "description": "Epoprostenol may increase the hypotensive activities of Cadralazine"
                    },
                    {
                        "drugbank-id": "DB13508",
                        "description": "Epoprostenol may increase the hypotensive activities of Cloranolol"
                    },
                    {
                        "drugbank-id": "DB13575",
                        "description": "Epoprostenol may increase the hypotensive activities of Bietaserpine"
                    },
                    {
                        "drugbank-id": "DB13604",
                        "description": "Epoprostenol may increase the hypotensive activities of Guanazodine"
                    },
                    {
                        "drugbank-id": "DB13631",
                        "description": "Epoprostenol may increase the hypotensive activities of Methoserpidine"
                    },
                    {
                        "drugbank-id": "DB13757",
                        "description": "Epoprostenol may increase the hypotensive activities of Epanolol"
                    },
                    {
                        "drugbank-id": "DB13779",
                        "description": "Epoprostenol may increase the hypotensive activities of Guanoclor"
                    },
                    {
                        "drugbank-id": "DB13801",
                        "description": "Epoprostenol may increase the hypotensive activities of Muzolimine"
                    },
                    {
                        "drugbank-id": "DB13803",
                        "description": "Epoprostenol may increase the hypotensive activities of Xipamide"
                    },
                    {
                        "drugbank-id": "DB13919",
                        "description": "Epoprostenol may increase the hypotensive activities of Candesartan"
                    },
                    {
                        "drugbank-id": "DB14068",
                        "description": "Epoprostenol may increase the hypotensive activities of Dexniguldipine"
                    },
                    {
                        "drugbank-id": "DB14125",
                        "description": "Epoprostenol may increase the hypotensive activities of Benazeprilat"
                    },
                    {
                        "drugbank-id": "DB14207",
                        "description": "Epoprostenol may increase the hypotensive activities of Fosinoprilat"
                    },
                    {
                        "drugbank-id": "DB14208",
                        "description": "Epoprostenol may increase the hypotensive activities of Ramiprilat"
                    },
                    {
                        "drugbank-id": "DB14213",
                        "description": "Epoprostenol may increase the hypotensive activities of Perindoprilat"
                    },
                    {
                        "drugbank-id": "DB14217",
                        "description": "Epoprostenol may increase the hypotensive activities of Quinaprilat"
                    },
                    {
                        "drugbank-id": "DB09237",
                        "description": "Epoprostenol may increase the hypotensive activities of Levamlodipine"
                    },
                    {
                        "drugbank-id": "DB14337",
                        "description": "Salvia miltiorrhiza root may increase the hypotensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00389",
                        "description": "Carbimazole may increase the anticoagulant activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00550",
                        "description": "Propylthiouracil may increase the anticoagulant activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB03374",
                        "description": "3 5 Diiodotyrosine may increase the anticoagulant activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB06715",
                        "description": "Potassium Iodide may increase the anticoagulant activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB07637",
                        "description": "Dibromotyrosine may increase the anticoagulant activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB13644",
                        "description": "Methylthiouracil may increase the anticoagulant activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB13804",
                        "description": "Benzylthiouracil may increase the anticoagulant activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00763",
                        "description": "Methimazole may increase the anticoagulant activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB09418",
                        "description": "Epoprostenol may increase the anticoagulant activities of Potassium perchlorate"
                    },
                    {
                        "drugbank-id": "DB00834",
                        "description": "The therapeutic efficacy of Epoprostenol can be decreased when used in combination with Mifepristone"
                    },
                    {
                        "drugbank-id": "DB04066",
                        "description": "The therapeutic efficacy of Epoprostenol can be decreased when used in combination with p Coumaric acid"
                    },
                    {
                        "drugbank-id": "DB04682",
                        "description": "The therapeutic efficacy of Epoprostenol can be decreased when used in combination with Octylphenoxy polyethoxyethanol"
                    },
                    {
                        "drugbank-id": "DB05830",
                        "description": "The therapeutic efficacy of Epoprostenol can be decreased when used in combination with Trestolone"
                    },
                    {
                        "drugbank-id": "DB06266",
                        "description": "The therapeutic efficacy of Epoprostenol can be decreased when used in combination with Lonidamine"
                    },
                    {
                        "drugbank-id": "DB08867",
                        "description": "The therapeutic efficacy of Epoprostenol can be decreased when used in combination with Ulipristal"
                    },
                    {
                        "drugbank-id": "DB09401",
                        "description": "The therapeutic efficacy of Epoprostenol can be decreased when used in combination with Isosorbide"
                    },
                    {
                        "drugbank-id": "DB11507",
                        "description": "The therapeutic efficacy of Epoprostenol can be decreased when used in combination with Cloprostenol"
                    },
                    {
                        "drugbank-id": "DB12025",
                        "description": "The therapeutic efficacy of Epoprostenol can be decreased when used in combination with Triptolide"
                    },
                    {
                        "drugbank-id": "DB13044",
                        "description": "The therapeutic efficacy of Epoprostenol can be decreased when used in combination with Gossypol"
                    },
                    {
                        "drugbank-id": "DB13310",
                        "description": "The therapeutic efficacy of Epoprostenol can be decreased when used in combination with Ormeloxifene"
                    },
                    {
                        "drugbank-id": "DB00601",
                        "description": "Linezolid may increase the hypotensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00614",
                        "description": "Furazolidone may increase the hypotensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00721",
                        "description": "Procaine may increase the hypotensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00752",
                        "description": "Tranylcypromine may increase the hypotensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00780",
                        "description": "Phenelzine may increase the hypotensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00805",
                        "description": "Minaprine may increase the hypotensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB01037",
                        "description": "Selegiline may increase the hypotensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB01168",
                        "description": "Procarbazine may increase the hypotensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB01171",
                        "description": "Moclobemide may increase the hypotensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB01247",
                        "description": "Isocarboxazid may increase the hypotensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB01367",
                        "description": "Rasagiline may increase the hypotensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB04017",
                        "description": "Clorgiline may increase the hypotensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB04818",
                        "description": "Iproniazid may increase the hypotensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB04820",
                        "description": "Nialamide may increase the hypotensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB06654",
                        "description": "Safinamide may increase the hypotensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB08550",
                        "description": "7 8 Dichloro 1 2 3 4 tetrahydroisoquinoline may increase the hypotensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB09241",
                        "description": "Methylene blue may increase the hypotensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB09243",
                        "description": "Hydracarbazine may increase the hypotensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB09244",
                        "description": "Pirlindole may increase the hypotensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB09245",
                        "description": "Toloxatone may increase the hypotensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB09246",
                        "description": "Benmoxin may increase the hypotensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB09248",
                        "description": "Mebanazine may increase the hypotensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB09249",
                        "description": "Octamoxin may increase the hypotensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB09250",
                        "description": "Pheniprazine may increase the hypotensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB09251",
                        "description": "Phenoxypropazine may increase the hypotensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB09252",
                        "description": "Pivhydrazine may increase the hypotensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB09253",
                        "description": "Safrazine may increase the hypotensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB09254",
                        "description": "Caroxazone may increase the hypotensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB13875",
                        "description": "Harmaline may increase the hypotensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB13876",
                        "description": "Brofaromine may increase the hypotensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00294",
                        "description": "Etonogestrel may decrease the anticoagulant activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00304",
                        "description": "Desogestrel may decrease the anticoagulant activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00351",
                        "description": "Megestrol acetate may decrease the anticoagulant activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00367",
                        "description": "Levonorgestrel may decrease the anticoagulant activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00378",
                        "description": "Dydrogesterone may decrease the anticoagulant activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00396",
                        "description": "Progesterone may decrease the anticoagulant activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00603",
                        "description": "Medroxyprogesterone acetate may decrease the anticoagulant activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00717",
                        "description": "Norethisterone may decrease the anticoagulant activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00823",
                        "description": "Ethynodiol diacetate may decrease the anticoagulant activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00957",
                        "description": "Norgestimate may decrease the anticoagulant activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB01395",
                        "description": "Drospirenone may decrease the anticoagulant activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB01431",
                        "description": "Allylestrenol may decrease the anticoagulant activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB04839",
                        "description": "Cyproterone acetate may decrease the anticoagulant activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB06713",
                        "description": "Norelgestromin may decrease the anticoagulant activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB06730",
                        "description": "Gestodene may decrease the anticoagulant activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB06789",
                        "description": "Hydroxyprogesterone caproate may decrease the anticoagulant activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB09123",
                        "description": "Dienogest may decrease the anticoagulant activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB09124",
                        "description": "Medrogestone may decrease the anticoagulant activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB09371",
                        "description": "Norethynodrel may decrease the anticoagulant activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB09389",
                        "description": "Norgestrel may decrease the anticoagulant activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB11372",
                        "description": "Altrenogest may decrease the anticoagulant activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB11619",
                        "description": "Gestrinone may decrease the anticoagulant activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB11636",
                        "description": "Nomegestrol may decrease the anticoagulant activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB12474",
                        "description": "Lynestrenol may decrease the anticoagulant activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB13230",
                        "description": "Gestonorone may decrease the anticoagulant activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB13528",
                        "description": "Chlormadinone may decrease the anticoagulant activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB13533",
                        "description": "Methylestrenolone may decrease the anticoagulant activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB13563",
                        "description": "Norgestrienone may decrease the anticoagulant activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB13602",
                        "description": "Promegestone may decrease the anticoagulant activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB13685",
                        "description": "Quingestanol may decrease the anticoagulant activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB13857",
                        "description": "Demegestone may decrease the anticoagulant activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB13866",
                        "description": "Etynodiol may decrease the anticoagulant activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB13981",
                        "description": "Nomegestrol acetate may decrease the anticoagulant activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB14570",
                        "description": "Hydroxyprogesterone may decrease the anticoagulant activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB14678",
                        "description": "Norethindrone enanthate may decrease the anticoagulant activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB14679",
                        "description": "Quingestanol acetate may decrease the anticoagulant activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00233",
                        "description": "The risk or severity of bleeding can be increased when Aminosalicylic acid is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB01294",
                        "description": "The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB06251",
                        "description": "The risk or severity of bleeding can be increased when Dersalazine is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB06807",
                        "description": "The risk or severity of bleeding can be increased when Phenyl aminosalicylate is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB09543",
                        "description": "The risk or severity of bleeding can be increased when Methyl salicylate is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB11079",
                        "description": "The risk or severity of bleeding can be increased when Trolamine salicylate is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB13509",
                        "description": "The risk or severity of bleeding can be increased when Aloxiprin is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB14006",
                        "description": "The risk or severity of bleeding can be increased when Choline salicylate is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB14026",
                        "description": "The risk or severity of bleeding can be increased when Thiosalicylic acid is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00241",
                        "description": "Butalbital may increase the hypotensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00312",
                        "description": "Pentobarbital may increase the hypotensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00418",
                        "description": "Secobarbital may increase the hypotensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00474",
                        "description": "Methohexital may increase the hypotensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00599",
                        "description": "Thiopental may increase the hypotensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00794",
                        "description": "Primidone may increase the hypotensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00849",
                        "description": "Methylphenobarbital may increase the hypotensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB01154",
                        "description": "Thiamylal may increase the hypotensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB01174",
                        "description": "Phenobarbital may increase the hypotensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB01351",
                        "description": "Amobarbital may increase the hypotensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB01355",
                        "description": "Hexobarbital may increase the hypotensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB01483",
                        "description": "Barbital may increase the hypotensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB09001",
                        "description": "Barbexaclone may increase the hypotensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00237",
                        "description": "Butabarbital may increase the hypotensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00054",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00063",
                        "description": "The risk or severity of bleeding can be increased when Eptifibatide is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00208",
                        "description": "The risk or severity of bleeding can be increased when Ticlopidine is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00261",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00758",
                        "description": "The risk or severity of bleeding can be increased when Clopidogrel is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00775",
                        "description": "The risk or severity of bleeding can be increased when Tirofiban is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00975",
                        "description": "The risk or severity of bleeding can be increased when Dipyridamole is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB01088",
                        "description": "The risk or severity of bleeding can be increased when Iloprost is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB01138",
                        "description": "The risk or severity of bleeding can be increased when Sulfinpyrazone is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB01166",
                        "description": "The risk or severity of bleeding can be increased when Cilostazol is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB01207",
                        "description": "The risk or severity of bleeding can be increased when Ridogrel is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB01236",
                        "description": "The risk or severity of bleeding can be increased when Sevoflurane is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00001",
                        "description": "The risk or severity of bleeding can be increased when Epoprostenol is combined with Lepirudin"
                    },
                    {
                        "drugbank-id": "DB00006",
                        "description": "The risk or severity of bleeding can be increased when Epoprostenol is combined with Bivalirudin"
                    },
                    {
                        "drugbank-id": "DB00009",
                        "description": "The risk or severity of bleeding can be increased when Epoprostenol is combined with Alteplase"
                    },
                    {
                        "drugbank-id": "DB00015",
                        "description": "The risk or severity of bleeding can be increased when Epoprostenol is combined with Reteplase"
                    },
                    {
                        "drugbank-id": "DB00029",
                        "description": "The risk or severity of bleeding can be increased when Epoprostenol is combined with Anistreplase"
                    },
                    {
                        "drugbank-id": "DB00031",
                        "description": "The risk or severity of bleeding can be increased when Epoprostenol is combined with Tenecteplase"
                    },
                    {
                        "drugbank-id": "DB00055",
                        "description": "The risk or severity of bleeding can be increased when Epoprostenol is combined with Drotrecogin alfa"
                    },
                    {
                        "drugbank-id": "DB00086",
                        "description": "The risk or severity of bleeding can be increased when Epoprostenol is combined with Streptokinase"
                    },
                    {
                        "drugbank-id": "DB00266",
                        "description": "The risk or severity of bleeding can be increased when Epoprostenol is combined with Dicoumarol"
                    },
                    {
                        "drugbank-id": "DB00278",
                        "description": "The risk or severity of bleeding can be increased when Epoprostenol is combined with Argatroban"
                    },
                    {
                        "drugbank-id": "DB00407",
                        "description": "The risk or severity of bleeding can be increased when Epoprostenol is combined with Ardeparin"
                    },
                    {
                        "drugbank-id": "DB00498",
                        "description": "The risk or severity of bleeding can be increased when Epoprostenol is combined with Phenindione"
                    },
                    {
                        "drugbank-id": "DB00569",
                        "description": "The risk or severity of bleeding can be increased when Epoprostenol is combined with Fondaparinux"
                    },
                    {
                        "drugbank-id": "DB00682",
                        "description": "The risk or severity of bleeding can be increased when Epoprostenol is combined with Warfarin"
                    },
                    {
                        "drugbank-id": "DB00946",
                        "description": "The risk or severity of bleeding can be increased when Epoprostenol is combined with Phenprocoumon"
                    },
                    {
                        "drugbank-id": "DB01109",
                        "description": "The risk or severity of bleeding can be increased when Epoprostenol is combined with Heparin"
                    },
                    {
                        "drugbank-id": "DB01225",
                        "description": "The risk or severity of bleeding can be increased when Epoprostenol is combined with Enoxaparin"
                    },
                    {
                        "drugbank-id": "DB01418",
                        "description": "The risk or severity of bleeding can be increased when Epoprostenol is combined with Acenocoumarol"
                    },
                    {
                        "drugbank-id": "DB03410",
                        "description": "The risk or severity of bleeding can be increased when Epoprostenol is combined with 4 hydroxycoumarin"
                    },
                    {
                        "drugbank-id": "DB04665",
                        "description": "The risk or severity of bleeding can be increased when Epoprostenol is combined with Coumarin"
                    },
                    {
                        "drugbank-id": "DB04898",
                        "description": "The risk or severity of bleeding can be increased when Epoprostenol is combined with Ximelagatran"
                    },
                    {
                        "drugbank-id": "DB04925",
                        "description": "The risk or severity of bleeding can be increased when Epoprostenol is combined with Desmoteplase"
                    },
                    {
                        "drugbank-id": "DB04932",
                        "description": "The risk or severity of bleeding can be increased when Epoprostenol is combined with Defibrotide"
                    },
                    {
                        "drugbank-id": "DB05099",
                        "description": "The risk or severity of bleeding can be increased when Epoprostenol is combined with Ancrod"
                    },
                    {
                        "drugbank-id": "DB05229",
                        "description": "The risk or severity of bleeding can be increased when Epoprostenol is combined with Beraprost"
                    },
                    {
                        "drugbank-id": "DB05254",
                        "description": "The risk or severity of bleeding can be increased when Epoprostenol is combined with Fibrinolysin"
                    },
                    {
                        "drugbank-id": "DB06209",
                        "description": "The risk or severity of bleeding can be increased when Epoprostenol is combined with Prasugrel"
                    },
                    {
                        "drugbank-id": "DB06271",
                        "description": "The risk or severity of bleeding can be increased when Epoprostenol is combined with Sulodexide"
                    },
                    {
                        "drugbank-id": "DB06294",
                        "description": "The risk or severity of bleeding can be increased when Epoprostenol is combined with Semuloparin"
                    },
                    {
                        "drugbank-id": "DB06406",
                        "description": "The risk or severity of bleeding can be increased when Epoprostenol is combined with Idraparinux"
                    },
                    {
                        "drugbank-id": "DB06441",
                        "description": "The risk or severity of bleeding can be increased when Epoprostenol is combined with Cangrelor"
                    },
                    {
                        "drugbank-id": "DB06543",
                        "description": "The risk or severity of bleeding can be increased when Epoprostenol is combined with Astaxanthin"
                    },
                    {
                        "drugbank-id": "DB06635",
                        "description": "The risk or severity of bleeding can be increased when Epoprostenol is combined with Otamixaban"
                    },
                    {
                        "drugbank-id": "DB06679",
                        "description": "The risk or severity of bleeding can be increased when Epoprostenol is combined with Amediplase"
                    },
                    {
                        "drugbank-id": "DB06754",
                        "description": "The risk or severity of bleeding can be increased when Epoprostenol is combined with Danaparoid"
                    },
                    {
                        "drugbank-id": "DB06779",
                        "description": "The risk or severity of bleeding can be increased when Epoprostenol is combined with Dalteparin"
                    },
                    {
                        "drugbank-id": "DB06822",
                        "description": "The risk or severity of bleeding can be increased when Epoprostenol is combined with Tinzaparin"
                    },
                    {
                        "drugbank-id": "DB07767",
                        "description": "The risk or severity of bleeding can be increased when Epoprostenol is combined with Ferulic acid"
                    },
                    {
                        "drugbank-id": "DB08496",
                        "description": "The risk or severity of bleeding can be increased when Epoprostenol is combined with R warfarin"
                    },
                    {
                        "drugbank-id": "DB08794",
                        "description": "The risk or severity of bleeding can be increased when Epoprostenol is combined with Ethyl biscoumacetate"
                    },
                    {
                        "drugbank-id": "DB08813",
                        "description": "The risk or severity of bleeding can be increased when Epoprostenol is combined with Nadroparin"
                    },
                    {
                        "drugbank-id": "DB08814",
                        "description": "The risk or severity of bleeding can be increased when Epoprostenol is combined with Triflusal"
                    },
                    {
                        "drugbank-id": "DB08816",
                        "description": "The risk or severity of bleeding can be increased when Epoprostenol is combined with Ticagrelor"
                    },
                    {
                        "drugbank-id": "DB08994",
                        "description": "The risk or severity of bleeding can be increased when Epoprostenol is combined with Ditazole"
                    },
                    {
                        "drugbank-id": "DB09125",
                        "description": "The risk or severity of bleeding can be increased when Epoprostenol is combined with Potassium citrate"
                    },
                    {
                        "drugbank-id": "DB09154",
                        "description": "The risk or severity of bleeding can be increased when Epoprostenol is combined with Sodium citrate"
                    },
                    {
                        "drugbank-id": "DB09255",
                        "description": "The risk or severity of bleeding can be increased when Epoprostenol is combined with Dextran"
                    },
                    {
                        "drugbank-id": "DB09258",
                        "description": "The risk or severity of bleeding can be increased when Epoprostenol is combined with Bemiparin"
                    },
                    {
                        "drugbank-id": "DB09260",
                        "description": "The risk or severity of bleeding can be increased when Epoprostenol is combined with Parnaparin"
                    },
                    {
                        "drugbank-id": "DB11095",
                        "description": "The risk or severity of bleeding can be increased when Epoprostenol is combined with Desirudin"
                    },
                    {
                        "drugbank-id": "DB11154",
                        "description": "The risk or severity of bleeding can be increased when Epoprostenol is combined with Zinc citrate"
                    },
                    {
                        "drugbank-id": "DB11166",
                        "description": "The risk or severity of bleeding can be increased when Epoprostenol is combined with Antithrombin Alfa"
                    },
                    {
                        "drugbank-id": "DB11312",
                        "description": "The risk or severity of bleeding can be increased when Epoprostenol is combined with Protein C"
                    },
                    {
                        "drugbank-id": "DB11598",
                        "description": "The risk or severity of bleeding can be increased when Epoprostenol is combined with Antithrombin III human"
                    },
                    {
                        "drugbank-id": "DB11984",
                        "description": "The risk or severity of bleeding can be increased when Epoprostenol is combined with Letaxaban"
                    },
                    {
                        "drugbank-id": "DB12289",
                        "description": "The risk or severity of bleeding can be increased when Epoprostenol is combined with Darexaban"
                    },
                    {
                        "drugbank-id": "DB12364",
                        "description": "The risk or severity of bleeding can be increased when Epoprostenol is combined with Betrixaban"
                    },
                    {
                        "drugbank-id": "DB12598",
                        "description": "The risk or severity of bleeding can be increased when Epoprostenol is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB12726",
                        "description": "The risk or severity of bleeding can be increased when Epoprostenol is combined with Monteplase"
                    },
                    {
                        "drugbank-id": "DB12831",
                        "description": "The risk or severity of bleeding can be increased when Epoprostenol is combined with Gabexate"
                    },
                    {
                        "drugbank-id": "DB13136",
                        "description": "The risk or severity of bleeding can be increased when Epoprostenol is combined with Fluindione"
                    },
                    {
                        "drugbank-id": "DB13149",
                        "description": "The risk or severity of bleeding can be increased when Epoprostenol is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB13199",
                        "description": "The risk or severity of bleeding can be increased when Epoprostenol is combined with Brinase"
                    },
                    {
                        "drugbank-id": "DB13275",
                        "description": "The risk or severity of bleeding can be increased when Epoprostenol is combined with Clorindione"
                    },
                    {
                        "drugbank-id": "DB13347",
                        "description": "The risk or severity of bleeding can be increased when Epoprostenol is combined with Diphenadione"
                    },
                    {
                        "drugbank-id": "DB13451",
                        "description": "The risk or severity of bleeding can be increased when Epoprostenol is combined with Tioclomarol"
                    },
                    {
                        "drugbank-id": "DB13616",
                        "description": "The risk or severity of bleeding can be increased when Epoprostenol is combined with Melagatran"
                    },
                    {
                        "drugbank-id": "DB13646",
                        "description": "The risk or severity of bleeding can be increased when Epoprostenol is combined with Saruplase"
                    },
                    {
                        "drugbank-id": "DB14055",
                        "description": "The risk or severity of bleeding can be increased when Epoprostenol is combined with S Warfarin"
                    },
                    {
                        "drugbank-id": "DB14094",
                        "description": "The risk or severity of bleeding can be increased when Epoprostenol is combined with Tocopherylquinone"
                    },
                    {
                        "drugbank-id": "DB14598",
                        "description": "The risk or severity of bleeding can be increased when Epoprostenol is combined with Edetate calcium disodium anhydrous"
                    },
                    {
                        "drugbank-id": "DB14726",
                        "description": "The risk or severity of bleeding can be increased when Epoprostenol is combined with Dabigatran"
                    },
                    {
                        "drugbank-id": "DB02709",
                        "description": "The risk or severity of bleeding can be increased when Resveratrol is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB04743",
                        "description": "The risk or severity of bleeding can be increased when Nimesulide is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB04905",
                        "description": "The risk or severity of bleeding can be increased when Tesmilifene is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB05266",
                        "description": "The risk or severity of bleeding can be increased when Ibudilast is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB05767",
                        "description": "The risk or severity of bleeding can be increased when Andrographolide is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB06081",
                        "description": "The risk or severity of bleeding can be increased when Caplacizumab is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB07615",
                        "description": "The risk or severity of bleeding can be increased when Tranilast is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB08887",
                        "description": "The risk or severity of bleeding can be increased when Icosapent ethyl is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB09283",
                        "description": "The risk or severity of bleeding can be increased when Trapidil is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB12092",
                        "description": "The risk or severity of bleeding can be increased when Naftopidil is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB12163",
                        "description": "The risk or severity of bleeding can be increased when Sarpogrelate is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB12321",
                        "description": "The risk or severity of bleeding can be increased when Ifetroban is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB12445",
                        "description": "The risk or severity of bleeding can be increased when Nitroaspirin is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB12465",
                        "description": "The risk or severity of bleeding can be increased when Ketanserin is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB12545",
                        "description": "The risk or severity of bleeding can be increased when Indobufen is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB12749",
                        "description": "The risk or severity of bleeding can be increased when Butylphthalide is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB12771",
                        "description": "The risk or severity of bleeding can be increased when Hydroxytyrosol is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB13036",
                        "description": "The risk or severity of bleeding can be increased when Ramatroban is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB13327",
                        "description": "The risk or severity of bleeding can be increased when Picotamide is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB13367",
                        "description": "The risk or severity of bleeding can be increased when Cloricromen is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB13400",
                        "description": "The risk or severity of bleeding can be increased when Linsidomine is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB13510",
                        "description": "The risk or severity of bleeding can be increased when Buflomedil is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB13929",
                        "description": "The risk or severity of bleeding can be increased when Relcovaptan is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00974",
                        "description": "The risk or severity of bleeding can be increased when Edetic acid is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB13124",
                        "description": "The risk or severity of bleeding can be increased when Troxerutin is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB09259",
                        "description": "The risk or severity of bleeding can be increased when Epoprostenol is combined with Reviparin"
                    },
                    {
                        "drugbank-id": "DB00268",
                        "description": "The risk or severity of adverse effects can be increased when Ropinirole is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00295",
                        "description": "The risk or severity of adverse effects can be increased when Morphine is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00297",
                        "description": "The risk or severity of adverse effects can be increased when Bupivacaine is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00334",
                        "description": "The risk or severity of adverse effects can be increased when Olanzapine is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00486",
                        "description": "The risk or severity of adverse effects can be increased when Nabilone is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00489",
                        "description": "The risk or severity of adverse effects can be increased when Sotalol is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00697",
                        "description": "The risk or severity of adverse effects can be increased when Tizanidine is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00714",
                        "description": "The risk or severity of adverse effects can be increased when Apomorphine is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00755",
                        "description": "The risk or severity of adverse effects can be increased when Tretinoin is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00883",
                        "description": "The risk or severity of adverse effects can be increased when Isosorbide dinitrate is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00922",
                        "description": "The risk or severity of adverse effects can be increased when Levosimendan is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB01113",
                        "description": "The risk or severity of adverse effects can be increased when Papaverine is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB01118",
                        "description": "The risk or severity of adverse effects can be increased when Amiodarone is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB01282",
                        "description": "The risk or severity of adverse effects can be increased when Carbetocin is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB01612",
                        "description": "The risk or severity of adverse effects can be increased when Amyl Nitrite is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB04899",
                        "description": "The risk or severity of adverse effects can be increased when Nesiritide is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB08822",
                        "description": "The risk or severity of adverse effects can be increased when Azilsartan medoxomil is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB09112",
                        "description": "The risk or severity of adverse effects can be increased when Nitrous acid is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB09232",
                        "description": "The risk or severity of adverse effects can be increased when Cilnidipine is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB09279",
                        "description": "The risk or severity of adverse effects can be increased when Fimasartan is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB09286",
                        "description": "The risk or severity of adverse effects can be increased when Pipamperone is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB09038",
                        "description": "The risk or severity of adverse effects can be increased when Empagliflozin is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00008",
                        "description": "The risk or severity of bleeding can be increased when Epoprostenol is combined with Peginterferon alfa 2a"
                    },
                    {
                        "drugbank-id": "DB00011",
                        "description": "The risk or severity of bleeding can be increased when Epoprostenol is combined with Interferon alfa n1"
                    },
                    {
                        "drugbank-id": "DB00018",
                        "description": "The risk or severity of bleeding can be increased when Epoprostenol is combined with Interferon alfa n3"
                    },
                    {
                        "drugbank-id": "DB00022",
                        "description": "The risk or severity of bleeding can be increased when Epoprostenol is combined with Peginterferon alfa 2b"
                    },
                    {
                        "drugbank-id": "DB00033",
                        "description": "The risk or severity of bleeding can be increased when Epoprostenol is combined with Interferon gamma 1b"
                    },
                    {
                        "drugbank-id": "DB00034",
                        "description": "The risk or severity of bleeding can be increased when Epoprostenol is combined with Interferon alfa 2a Recombinant"
                    },
                    {
                        "drugbank-id": "DB00056",
                        "description": "The risk or severity of bleeding can be increased when Epoprostenol is combined with Gemtuzumab ozogamicin"
                    },
                    {
                        "drugbank-id": "DB00068",
                        "description": "The risk or severity of bleeding can be increased when Epoprostenol is combined with Interferon beta 1b"
                    },
                    {
                        "drugbank-id": "DB00069",
                        "description": "The risk or severity of bleeding can be increased when Epoprostenol is combined with Interferon alfacon 1"
                    },
                    {
                        "drugbank-id": "DB00087",
                        "description": "The risk or severity of bleeding can be increased when Epoprostenol is combined with Alemtuzumab"
                    },
                    {
                        "drugbank-id": "DB00105",
                        "description": "The risk or severity of bleeding can be increased when Epoprostenol is combined with Interferon alfa 2b"
                    },
                    {
                        "drugbank-id": "DB00120",
                        "description": "The risk or severity of bleeding can be increased when Epoprostenol is combined with Phenylalanine"
                    },
                    {
                        "drugbank-id": "DB00242",
                        "description": "The risk or severity of bleeding can be increased when Epoprostenol is combined with Cladribine"
                    },
                    {
                        "drugbank-id": "DB00276",
                        "description": "The risk or severity of bleeding can be increased when Epoprostenol is combined with Amsacrine"
                    },
                    {
                        "drugbank-id": "DB00291",
                        "description": "The risk or severity of bleeding can be increased when Epoprostenol is combined with Chlorambucil"
                    },
                    {
                        "drugbank-id": "DB00293",
                        "description": "The risk or severity of bleeding can be increased when Epoprostenol is combined with Raltitrexed"
                    },
                    {
                        "drugbank-id": "DB00305",
                        "description": "The risk or severity of bleeding can be increased when Epoprostenol is combined with Mitomycin"
                    },
                    {
                        "drugbank-id": "DB00307",
                        "description": "The risk or severity of bleeding can be increased when Epoprostenol is combined with Bexarotene"
                    },
                    {
                        "drugbank-id": "DB00309",
                        "description": "The risk or severity of bleeding can be increased when Epoprostenol is combined with Vindesine"
                    },
                    {
                        "drugbank-id": "DB00352",
                        "description": "The risk or severity of bleeding can be increased when Epoprostenol is combined with Tioguanine"
                    },
                    {
                        "drugbank-id": "DB00361",
                        "description": "The risk or severity of bleeding can be increased when Epoprostenol is combined with Vinorelbine"
                    },
                    {
                        "drugbank-id": "DB00428",
                        "description": "The risk or severity of bleeding can be increased when Epoprostenol is combined with Streptozocin"
                    },
                    {
                        "drugbank-id": "DB00444",
                        "description": "The risk or severity of bleeding can be increased when Epoprostenol is combined with Teniposide"
                    },
                    {
                        "drugbank-id": "DB00445",
                        "description": "The risk or severity of bleeding can be increased when Epoprostenol is combined with Epirubicin"
                    },
                    {
                        "drugbank-id": "DB00446",
                        "description": "The risk or severity of bleeding can be increased when Epoprostenol is combined with Chloramphenicol"
                    },
                    {
                        "drugbank-id": "DB00488",
                        "description": "The risk or severity of bleeding can be increased when Epoprostenol is combined with Altretamine"
                    },
                    {
                        "drugbank-id": "DB00495",
                        "description": "The risk or severity of bleeding can be increased when Epoprostenol is combined with Zidovudine"
                    },
                    {
                        "drugbank-id": "DB00526",
                        "description": "The risk or severity of bleeding can be increased when Epoprostenol is combined with Oxaliplatin"
                    },
                    {
                        "drugbank-id": "DB00531",
                        "description": "The risk or severity of bleeding can be increased when Epoprostenol is combined with Cyclophosphamide"
                    },
                    {
                        "drugbank-id": "DB00544",
                        "description": "The risk or severity of bleeding can be increased when Epoprostenol is combined with Fluorouracil"
                    },
                    {
                        "drugbank-id": "DB00570",
                        "description": "The risk or severity of bleeding can be increased when Epoprostenol is combined with Vinblastine"
                    },
                    {
                        "drugbank-id": "DB00619",
                        "description": "The risk or severity of bleeding can be increased when Epoprostenol is combined with Imatinib"
                    },
                    {
                        "drugbank-id": "DB00694",
                        "description": "The risk or severity of bleeding can be increased when Epoprostenol is combined with Daunorubicin"
                    },
                    {
                        "drugbank-id": "DB00762",
                        "description": "The risk or severity of bleeding can be increased when Epoprostenol is combined with Irinotecan"
                    },
                    {
                        "drugbank-id": "DB00773",
                        "description": "The risk or severity of bleeding can be increased when Epoprostenol is combined with Etoposide"
                    },
                    {
                        "drugbank-id": "DB00859",
                        "description": "The risk or severity of bleeding can be increased when Epoprostenol is combined with Penicillamine"
                    },
                    {
                        "drugbank-id": "DB00877",
                        "description": "The risk or severity of bleeding can be increased when Epoprostenol is combined with Sirolimus"
                    },
                    {
                        "drugbank-id": "DB00888",
                        "description": "The risk or severity of bleeding can be increased when Epoprostenol is combined with Mechlorethamine"
                    },
                    {
                        "drugbank-id": "DB00970",
                        "description": "The risk or severity of bleeding can be increased when Epoprostenol is combined with Dactinomycin"
                    },
                    {
                        "drugbank-id": "DB00987",
                        "description": "The risk or severity of bleeding can be increased when Epoprostenol is combined with Cytarabine"
                    },
                    {
                        "drugbank-id": "DB00997",
                        "description": "The risk or severity of bleeding can be increased when Epoprostenol is combined with Doxorubicin"
                    },
                    {
                        "drugbank-id": "DB01005",
                        "description": "The risk or severity of bleeding can be increased when Epoprostenol is combined with Hydroxyurea"
                    },
                    {
                        "drugbank-id": "DB01008",
                        "description": "The risk or severity of bleeding can be increased when Epoprostenol is combined with Busulfan"
                    },
                    {
                        "drugbank-id": "DB01033",
                        "description": "The risk or severity of bleeding can be increased when Epoprostenol is combined with Mercaptopurine"
                    },
                    {
                        "drugbank-id": "DB01042",
                        "description": "The risk or severity of bleeding can be increased when Epoprostenol is combined with Melphalan"
                    },
                    {
                        "drugbank-id": "DB01073",
                        "description": "The risk or severity of bleeding can be increased when Epoprostenol is combined with Fludarabine"
                    },
                    {
                        "drugbank-id": "DB01177",
                        "description": "The risk or severity of bleeding can be increased when Epoprostenol is combined with Idarubicin"
                    },
                    {
                        "drugbank-id": "DB01204",
                        "description": "The risk or severity of bleeding can be increased when Epoprostenol is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB01206",
                        "description": "The risk or severity of bleeding can be increased when Epoprostenol is combined with Lomustine"
                    },
                    {
                        "drugbank-id": "DB01248",
                        "description": "The risk or severity of bleeding can be increased when Epoprostenol is combined with Docetaxel"
                    },
                    {
                        "drugbank-id": "DB01262",
                        "description": "The risk or severity of bleeding can be increased when Epoprostenol is combined with Decitabine"
                    },
                    {
                        "drugbank-id": "DB01280",
                        "description": "The risk or severity of bleeding can be increased when Epoprostenol is combined with Nelarabine"
                    },
                    {
                        "drugbank-id": "DB01590",
                        "description": "The risk or severity of bleeding can be increased when Epoprostenol is combined with Everolimus"
                    },
                    {
                        "drugbank-id": "DB02546",
                        "description": "The risk or severity of bleeding can be increased when Epoprostenol is combined with Vorinostat"
                    },
                    {
                        "drugbank-id": "DB04572",
                        "description": "The risk or severity of bleeding can be increased when Epoprostenol is combined with Thiotepa"
                    },
                    {
                        "drugbank-id": "DB04845",
                        "description": "The risk or severity of bleeding can be increased when Epoprostenol is combined with Ixabepilone"
                    },
                    {
                        "drugbank-id": "DB04868",
                        "description": "The risk or severity of bleeding can be increased when Epoprostenol is combined with Nilotinib"
                    },
                    {
                        "drugbank-id": "DB05015",
                        "description": "The risk or severity of bleeding can be increased when Epoprostenol is combined with Belinostat"
                    },
                    {
                        "drugbank-id": "DB05109",
                        "description": "The risk or severity of bleeding can be increased when Epoprostenol is combined with Trabectedin"
                    },
                    {
                        "drugbank-id": "DB05258",
                        "description": "The risk or severity of bleeding can be increased when Epoprostenol is combined with Interferon alfa"
                    },
                    {
                        "drugbank-id": "DB05472",
                        "description": "The risk or severity of bleeding can be increased when Epoprostenol is combined with Human interferon omega 1"
                    },
                    {
                        "drugbank-id": "DB05773",
                        "description": "The risk or severity of bleeding can be increased when Epoprostenol is combined with Trastuzumab emtansine"
                    },
                    {
                        "drugbank-id": "DB06287",
                        "description": "The risk or severity of bleeding can be increased when Epoprostenol is combined with Temsirolimus"
                    },
                    {
                        "drugbank-id": "DB06616",
                        "description": "The risk or severity of bleeding can be increased when Epoprostenol is combined with Bosutinib"
                    },
                    {
                        "drugbank-id": "DB06769",
                        "description": "The risk or severity of bleeding can be increased when Epoprostenol is combined with Bendamustine"
                    },
                    {
                        "drugbank-id": "DB06772",
                        "description": "The risk or severity of bleeding can be increased when Epoprostenol is combined with Cabazitaxel"
                    },
                    {
                        "drugbank-id": "DB08871",
                        "description": "The risk or severity of bleeding can be increased when Epoprostenol is combined with Eribulin"
                    },
                    {
                        "drugbank-id": "DB08889",
                        "description": "The risk or severity of bleeding can be increased when Epoprostenol is combined with Carfilzomib"
                    },
                    {
                        "drugbank-id": "DB08895",
                        "description": "The risk or severity of bleeding can be increased when Epoprostenol is combined with Tofacitinib"
                    },
                    {
                        "drugbank-id": "DB08901",
                        "description": "The risk or severity of bleeding can be increased when Epoprostenol is combined with Ponatinib"
                    },
                    {
                        "drugbank-id": "DB09042",
                        "description": "The risk or severity of bleeding can be increased when Epoprostenol is combined with Tedizolid phosphate"
                    },
                    {
                        "drugbank-id": "DB09052",
                        "description": "The risk or severity of bleeding can be increased when Epoprostenol is combined with Blinatumomab"
                    },
                    {
                        "drugbank-id": "DB09073",
                        "description": "The risk or severity of bleeding can be increased when Epoprostenol is combined with Palbociclib"
                    },
                    {
                        "drugbank-id": "DB09074",
                        "description": "The risk or severity of bleeding can be increased when Epoprostenol is combined with Olaparib"
                    },
                    {
                        "drugbank-id": "DB09122",
                        "description": "The risk or severity of bleeding can be increased when Epoprostenol is combined with Peginterferon beta 1a"
                    },
                    {
                        "drugbank-id": "DB12814",
                        "description": "The risk or severity of bleeding can be increased when Epoprostenol is combined with Cepeginterferon alfa 2B"
                    },
                    {
                        "drugbank-id": "DB03404",
                        "description": "Hemin may increase the anticoagulant activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB13783",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Acemetacin is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB09236",
                        "description": "Epoprostenol may increase the hypotensive activities of Lacidipine"
                    },
                    {
                        "drugbank-id": "DB00898",
                        "description": "Ethanol may increase the hypotensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB09227",
                        "description": "Epoprostenol may increase the antihypertensive activities of Barnidipine"
                    },
                    {
                        "drugbank-id": "DB00624",
                        "description": "Testosterone may increase the anticoagulant activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB01420",
                        "description": "Testosterone propionate may increase the anticoagulant activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB01481",
                        "description": "1 Testosterone may increase the anticoagulant activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB01485",
                        "description": "4 Hydroxytestosterone may increase the anticoagulant activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB01510",
                        "description": "Dehydrochloromethyltestosterone may increase the anticoagulant activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB01541",
                        "description": "Boldenone may increase the anticoagulant activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB01543",
                        "description": "18 methyl 19 nortestosterone may increase the anticoagulant activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB01564",
                        "description": "Calusterone may increase the anticoagulant activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB01569",
                        "description": "Formebolone may increase the anticoagulant activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB01572",
                        "description": "Methyl 1 testosterone may increase the anticoagulant activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB07447",
                        "description": "5beta dihydrotestosterone may increase the anticoagulant activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB08619",
                        "description": "Testosterone succinate may increase the anticoagulant activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB11429",
                        "description": "Mibolerone may increase the anticoagulant activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB13943",
                        "description": "Testosterone cypionate may increase the anticoagulant activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB13944",
                        "description": "Testosterone enanthate may increase the anticoagulant activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB13946",
                        "description": "Testosterone undecanoate may increase the anticoagulant activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB13947",
                        "description": "Testosterone enantate benzilic acid hydrazone may increase the anticoagulant activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB13951",
                        "description": "Stanolone acetate may increase the anticoagulant activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB13958",
                        "description": "Trestolone acetate may increase the anticoagulant activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB14093",
                        "description": "1 2 6 7 3H Testosterone may increase the anticoagulant activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB14655",
                        "description": "Drostanolone propionate may increase the anticoagulant activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB11051",
                        "description": "The risk or severity of adverse effects can be increased when Epoprostenol is combined with Azficel T"
                    },
                    {
                        "drugbank-id": "DB13967",
                        "description": "The therapeutic efficacy of Epoprostenol can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB09568",
                        "description": "The therapeutic efficacy of Epoprostenol can be increased when used in combination with Omega 3 carboxylic acids"
                    },
                    {
                        "drugbank-id": "DB00025",
                        "description": "The therapeutic efficacy of Antihemophilic factor human recombinant can be decreased when used in combination with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00036",
                        "description": "The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00100",
                        "description": "The therapeutic efficacy of Coagulation Factor IX Recombinant can be decreased when used in combination with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00258",
                        "description": "The therapeutic efficacy of Calcium acetate can be decreased when used in combination with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB01164",
                        "description": "The therapeutic efficacy of Calcium chloride can be decreased when used in combination with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB01373",
                        "description": "The therapeutic efficacy of Calcium can be decreased when used in combination with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB01783",
                        "description": "The therapeutic efficacy of Pantothenic acid can be decreased when used in combination with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB01942",
                        "description": "The therapeutic efficacy of Formic acid can be decreased when used in combination with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB02261",
                        "description": "The therapeutic efficacy of Platelet Activating Factor can be decreased when used in combination with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB06724",
                        "description": "The therapeutic efficacy of Calcium carbonate can be decreased when used in combination with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB09109",
                        "description": "The therapeutic efficacy of Turoctocog alfa can be decreased when used in combination with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB09222",
                        "description": "The therapeutic efficacy of Fibrinogen human can be decreased when used in combination with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB09310",
                        "description": "The therapeutic efficacy of Catridecacog can be decreased when used in combination with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB09329",
                        "description": "The therapeutic efficacy of Antihemophilic Factor Recombinant PEGylated can be decreased when used in combination with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB11093",
                        "description": "The therapeutic efficacy of Calcium citrate can be decreased when used in combination with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB11126",
                        "description": "The therapeutic efficacy of Calcium gluconate can be decreased when used in combination with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB11168",
                        "description": "The therapeutic efficacy of Calcium threonate can be decreased when used in combination with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB11311",
                        "description": "The therapeutic efficacy of Prothrombin can be decreased when used in combination with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB11330",
                        "description": "The therapeutic efficacy of Factor IX Complex Human can be decreased when used in combination with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB11348",
                        "description": "The therapeutic efficacy of Calcium Phosphate can be decreased when used in combination with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB11606",
                        "description": "The therapeutic efficacy of Susoctocog alfa can be decreased when used in combination with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB11608",
                        "description": "The therapeutic efficacy of Eftrenonacog alfa can be decreased when used in combination with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB11668",
                        "description": "The therapeutic efficacy of Rusalatide acetate can be decreased when used in combination with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB12409",
                        "description": "The therapeutic efficacy of Vatreptacog alfa can be decreased when used in combination with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB12909",
                        "description": "The therapeutic efficacy of Factor XIII human can be decreased when used in combination with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB13133",
                        "description": "The therapeutic efficacy of Von Willebrand Factor Human can be decreased when used in combination with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB13148",
                        "description": "The therapeutic efficacy of Coagulation factor X human can be decreased when used in combination with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB13150",
                        "description": "The therapeutic efficacy of Coagulation factor VII human can be decreased when used in combination with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB13151",
                        "description": "The therapeutic efficacy of Anti inhibitor coagulant complex can be decreased when used in combination with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB13152",
                        "description": "The therapeutic efficacy of Coagulation Factor IX Human can be decreased when used in combination with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB13192",
                        "description": "The therapeutic efficacy of Antihemophilic factor human can be decreased when used in combination with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB13197",
                        "description": "The therapeutic efficacy of Kallidinogenase can be decreased when used in combination with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB13201",
                        "description": "The therapeutic efficacy of Trenonacog alfa can be decreased when used in combination with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB13884",
                        "description": "The therapeutic efficacy of Albutrepenonacog alfa can be decreased when used in combination with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB13923",
                        "description": "The therapeutic efficacy of Emicizumab can be decreased when used in combination with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB13933",
                        "description": "The therapeutic efficacy of Nonacog beta pegol can be decreased when used in combination with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB13999",
                        "description": "The therapeutic efficacy of Moroctocog alfa can be decreased when used in combination with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB14473",
                        "description": "The therapeutic efficacy of Beroctocog alfa can be decreased when used in combination with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB14562",
                        "description": "The therapeutic efficacy of Andexanet alfa can be decreased when used in combination with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB14577",
                        "description": "The therapeutic efficacy of Calcium cation can be decreased when used in combination with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB14700",
                        "description": "The therapeutic efficacy of Damoctocog alfa pegol can be decreased when used in combination with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB14738",
                        "description": "The therapeutic efficacy of Turoctocog alfa pegol can be decreased when used in combination with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB06731",
                        "description": "The risk or severity of hemorrhage can be increased when Seproxetine is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00176",
                        "description": "The risk or severity of hemorrhage can be increased when Fluvoxamine is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00215",
                        "description": "The risk or severity of hemorrhage can be increased when Citalopram is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00472",
                        "description": "The risk or severity of hemorrhage can be increased when Fluoxetine is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00715",
                        "description": "The risk or severity of hemorrhage can be increased when Paroxetine is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB01105",
                        "description": "The risk or severity of hemorrhage can be increased when Sibutramine is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB01149",
                        "description": "The risk or severity of hemorrhage can be increased when Nefazodone is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB04832",
                        "description": "The risk or severity of hemorrhage can be increased when Zimelidine is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB04884",
                        "description": "The risk or severity of hemorrhage can be increased when Dapoxetine is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB04896",
                        "description": "The risk or severity of hemorrhage can be increased when Milnacipran is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB06700",
                        "description": "The risk or severity of hemorrhage can be increased when Desvenlafaxine is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB08918",
                        "description": "The risk or severity of hemorrhage can be increased when Levomilnacipran is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB08953",
                        "description": "The risk or severity of hemorrhage can be increased when Indalpine is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB12693",
                        "description": "The risk or severity of hemorrhage can be increased when Ritanserin is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB13233",
                        "description": "The risk or severity of hemorrhage can be increased when Alaproclate is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00285",
                        "description": "Venlafaxine may increase the antiplatelet activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00091",
                        "description": "Cyclosporine may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00229",
                        "description": "Cefotiam may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00267",
                        "description": "Cefmenoxime may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00274",
                        "description": "Cefmetazole may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00282",
                        "description": "Pamidronic acid may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00300",
                        "description": "Tenofovir disoproxil may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00369",
                        "description": "Cidofovir may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00384",
                        "description": "Triamterene may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00430",
                        "description": "Cefpiramide may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00438",
                        "description": "Ceftazidime may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00447",
                        "description": "Loracarbef may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00456",
                        "description": "Cefalotin may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00493",
                        "description": "Cefotaxime may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00529",
                        "description": "Foscarnet may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00563",
                        "description": "Methotrexate may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00567",
                        "description": "Cephalexin may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00577",
                        "description": "Valaciclovir may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00626",
                        "description": "Bacitracin may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00681",
                        "description": "Amphotericin B may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00689",
                        "description": "Cephaloglycin may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00718",
                        "description": "Adefovir dipivoxil may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00738",
                        "description": "Pentamidine may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00742",
                        "description": "Mannitol may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00787",
                        "description": "Acyclovir may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00833",
                        "description": "Cefaclor may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00864",
                        "description": "Tacrolimus may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00903",
                        "description": "Etacrynic acid may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00923",
                        "description": "Ceforanide may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00958",
                        "description": "Carboplatin may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01066",
                        "description": "Cefditoren may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01072",
                        "description": "Atazanavir may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01111",
                        "description": "Colistimethate may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01112",
                        "description": "Cefuroxime may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01139",
                        "description": "Cefapirin may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01140",
                        "description": "Cefadroxil may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01150",
                        "description": "Cefprozil may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01212",
                        "description": "Ceftriaxone may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01326",
                        "description": "Cefamandole may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01327",
                        "description": "Cefazolin may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01328",
                        "description": "Cefonicid may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01329",
                        "description": "Cefoperazone may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01330",
                        "description": "Cefotetan may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01331",
                        "description": "Cefoxitin may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01332",
                        "description": "Ceftizoxime may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01333",
                        "description": "Cefradine may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01413",
                        "description": "Cefepime may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01414",
                        "description": "Cefacetrile may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01415",
                        "description": "Ceftibuten may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01416",
                        "description": "Cefpodoxime may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01601",
                        "description": "Lopinavir may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB02247",
                        "description": "Hydrolyzed Cephalothin may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB03450",
                        "description": "Cephalothin Group may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB04570",
                        "description": "Latamoxef may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB04918",
                        "description": "Ceftobiprole may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06590",
                        "description": "Ceftaroline fosamil may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09008",
                        "description": "Cefaloridine may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09062",
                        "description": "Cefminox may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09299",
                        "description": "Tenofovir alafenamide may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11367",
                        "description": "Cefroxadine may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11935",
                        "description": "Flomoxef may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB12151",
                        "description": "Brincidofovir may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13266",
                        "description": "Cefatrizine may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13461",
                        "description": "Cefcapene may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13470",
                        "description": "Cefodizime may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13499",
                        "description": "Cefsulodin may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13504",
                        "description": "Cefetamet may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13638",
                        "description": "Cefbuperazone may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13667",
                        "description": "Cefozopran may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13682",
                        "description": "Cefpirome may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13778",
                        "description": "Cefazedone may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13821",
                        "description": "Ceftezole may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13868",
                        "description": "Adefovir may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB14126",
                        "description": "Tenofovir may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB14713",
                        "description": "Inotersen may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01438",
                        "description": "Phenazopyridine may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB15066",
                        "description": "Givosiran may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01356",
                        "description": "Lithium cation may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB14507",
                        "description": "Lithium citrate may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00452",
                        "description": "Framycetin may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01421",
                        "description": "Paromomycin may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB04263",
                        "description": "Geneticin may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB04626",
                        "description": "Apramycin may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB04808",
                        "description": "Neamine may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08437",
                        "description": "Puromycin may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11512",
                        "description": "Dihydrostreptomycin may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11520",
                        "description": "Hygromycin B may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00007",
                        "description": "Leuprolide may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00014",
                        "description": "Goserelin may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00017",
                        "description": "Salmon calcitonin may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00035",
                        "description": "Desmopressin may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00041",
                        "description": "Aldesleukin may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00080",
                        "description": "Daptomycin may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00115",
                        "description": "Cyanocobalamin may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00158",
                        "description": "Folic acid may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00165",
                        "description": "Pyridoxine may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00185",
                        "description": "Cevimeline may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00186",
                        "description": "Lorazepam may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00193",
                        "description": "Tramadol may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00196",
                        "description": "Fluconazole may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00198",
                        "description": "Oseltamivir may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00200",
                        "description": "Hydroxocobalamin may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00213",
                        "description": "Pantoprazole may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00225",
                        "description": "Gadodiamide may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00230",
                        "description": "Pregabalin may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00231",
                        "description": "Temazepam may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00243",
                        "description": "Ranolazine may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00245",
                        "description": "Benzatropine may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00262",
                        "description": "Carmustine may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00271",
                        "description": "Diatrizoate may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00273",
                        "description": "Topiramate may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00279",
                        "description": "Liothyronine may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00280",
                        "description": "Disopyramide may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00284",
                        "description": "Acarbose may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00289",
                        "description": "Atomoxetine may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00290",
                        "description": "Bleomycin may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00292",
                        "description": "Etomidate may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00296",
                        "description": "Ropivacaine may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00303",
                        "description": "Ertapenem may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00308",
                        "description": "Ibutilide may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00316",
                        "description": "Acetaminophen may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00319",
                        "description": "Piperacillin may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00322",
                        "description": "Floxuridine may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00323",
                        "description": "Tolcapone may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00327",
                        "description": "Hydromorphone may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00330",
                        "description": "Ethambutol may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00331",
                        "description": "Metformin may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00333",
                        "description": "Methadone may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00339",
                        "description": "Pyrazinamide may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00341",
                        "description": "Cetirizine may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00349",
                        "description": "Clobazam may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00355",
                        "description": "Aztreonam may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00356",
                        "description": "Chlorzoxazone may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00359",
                        "description": "Sulfadiazine may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00363",
                        "description": "Clozapine may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00364",
                        "description": "Sucralfate may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00372",
                        "description": "Thiethylperazine may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00377",
                        "description": "Palonosetron may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00380",
                        "description": "Dexrazoxane may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00398",
                        "description": "Sorafenib may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00402",
                        "description": "Eszopiclone may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00404",
                        "description": "Alprazolam may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00412",
                        "description": "Rosiglitazone may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00413",
                        "description": "Pramipexole may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00415",
                        "description": "Ampicillin may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00432",
                        "description": "Trifluridine may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00435",
                        "description": "Nitric Oxide may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00437",
                        "description": "Allopurinol may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00440",
                        "description": "Trimethoprim may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00441",
                        "description": "Gemcitabine may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00477",
                        "description": "Chlorpromazine may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00480",
                        "description": "Lenalidomide may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00490",
                        "description": "Buspirone may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00499",
                        "description": "Flutamide may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00501",
                        "description": "Cimetidine may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00502",
                        "description": "Haloperidol may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00535",
                        "description": "Cefdinir may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00537",
                        "description": "Ciprofloxacin may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00548",
                        "description": "Azelaic acid may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00553",
                        "description": "Methoxsalen may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00555",
                        "description": "Lamotrigine may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00558",
                        "description": "Zanamivir may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00591",
                        "description": "Fluocinolone acetonide may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00597",
                        "description": "Gadoteridol may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00608",
                        "description": "Chloroquine may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00628",
                        "description": "Clorazepic acid may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00631",
                        "description": "Clofarabine may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00633",
                        "description": "Dexmedetomidine may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00635",
                        "description": "Prednisone may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00651",
                        "description": "Dyphylline may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00660",
                        "description": "Metaxalone may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00661",
                        "description": "Verapamil may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00665",
                        "description": "Nilutamide may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00669",
                        "description": "Sumatriptan may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00672",
                        "description": "Chlorpropamide may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00683",
                        "description": "Midazolam may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00688",
                        "description": "Mycophenolate mofetil may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00690",
                        "description": "Flurazepam may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00698",
                        "description": "Nitrofurantoin may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00706",
                        "description": "Tamsulosin may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00709",
                        "description": "Lamivudine may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00713",
                        "description": "Oxacillin may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00716",
                        "description": "Nedocromil may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00730",
                        "description": "Thiabendazole may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00731",
                        "description": "Nateglinide may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00733",
                        "description": "Pralidoxime may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00743",
                        "description": "Gadobenic acid may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00759",
                        "description": "Tetracycline may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00760",
                        "description": "Meropenem may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00761",
                        "description": "Potassium chloride may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00782",
                        "description": "Propantheline may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00789",
                        "description": "Gadopentetic acid may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00804",
                        "description": "Dicyclomine may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00811",
                        "description": "Ribavirin may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00828",
                        "description": "Fosfomycin may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00829",
                        "description": "Diazepam may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00839",
                        "description": "Tolazamide may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00841",
                        "description": "Dobutamine may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00842",
                        "description": "Oxazepam may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00851",
                        "description": "Dacarbazine may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00853",
                        "description": "Temozolomide may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00863",
                        "description": "Ranitidine may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00871",
                        "description": "Terbutaline may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00894",
                        "description": "Testolactone may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00897",
                        "description": "Triazolam may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00900",
                        "description": "Didanosine may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00911",
                        "description": "Tinidazole may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00915",
                        "description": "Amantadine may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00918",
                        "description": "Almotriptan may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00928",
                        "description": "Azacitidine may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00934",
                        "description": "Maprotiline may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00951",
                        "description": "Isoniazid may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00953",
                        "description": "Rizatriptan may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00961",
                        "description": "Mepivacaine may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00962",
                        "description": "Zaleplon may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00980",
                        "description": "Ramelteon may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00988",
                        "description": "Dopamine may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00993",
                        "description": "Azathioprine may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00995",
                        "description": "Auranofin may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01001",
                        "description": "Salbutamol may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01002",
                        "description": "Levobupivacaine may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01004",
                        "description": "Ganciclovir may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01010",
                        "description": "Edrophonium may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01011",
                        "description": "Metyrapone may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01015",
                        "description": "Sulfamethoxazole may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01022",
                        "description": "Phylloquinone may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01024",
                        "description": "Mycophenolic acid may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01030",
                        "description": "Topotecan may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01032",
                        "description": "Probenecid may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01036",
                        "description": "Tolterodine may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01039",
                        "description": "Fenofibrate may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01043",
                        "description": "Memantine may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01046",
                        "description": "Lubiprostone may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01048",
                        "description": "Abacavir may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01060",
                        "description": "Amoxicillin may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01067",
                        "description": "Glipizide may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01068",
                        "description": "Clonazepam may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01069",
                        "description": "Promethazine may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01093",
                        "description": "Dimethyl sulfoxide may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01099",
                        "description": "Flucytosine may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01101",
                        "description": "Capecitabine may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01124",
                        "description": "Tolbutamide may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01129",
                        "description": "Rabeprazole may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01133",
                        "description": "Tiludronic acid may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01135",
                        "description": "Doxacurium may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01137",
                        "description": "Levofloxacin may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01148",
                        "description": "Flavoxate may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01156",
                        "description": "Bupropion may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01157",
                        "description": "Trimetrexate may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01169",
                        "description": "Arsenic trioxide may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01183",
                        "description": "Naloxone may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01205",
                        "description": "Flumazenil may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01213",
                        "description": "Fomepizole may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01215",
                        "description": "Estazolam may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01221",
                        "description": "Ketamine may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01222",
                        "description": "Budesonide may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01233",
                        "description": "Metoclopramide may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01241",
                        "description": "Epoprostenol may decrease the excretion rate of Gemfibrozil which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01249",
                        "description": "Epoprostenol may decrease the excretion rate of Iodixanol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01261",
                        "description": "Epoprostenol may decrease the excretion rate of Sitagliptin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01267",
                        "description": "Epoprostenol may decrease the excretion rate of Paliperidone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01273",
                        "description": "Epoprostenol may decrease the excretion rate of Varenicline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01274",
                        "description": "Epoprostenol may decrease the excretion rate of Arformoterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01394",
                        "description": "Epoprostenol may decrease the excretion rate of Colchicine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01409",
                        "description": "Epoprostenol may decrease the excretion rate of Tiotropium which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01427",
                        "description": "Epoprostenol may decrease the excretion rate of Amrinone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01428",
                        "description": "Epoprostenol may decrease the excretion rate of Oxybenzone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01550",
                        "description": "Epoprostenol may decrease the excretion rate of Fenproporex which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01558",
                        "description": "Epoprostenol may decrease the excretion rate of Bromazepam which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01563",
                        "description": "Epoprostenol may decrease the excretion rate of Chloral hydrate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01577",
                        "description": "Epoprostenol may decrease the excretion rate of Metamfetamine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01587",
                        "description": "Epoprostenol may decrease the excretion rate of Ketazolam which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01610",
                        "description": "Epoprostenol may decrease the excretion rate of Valganciclovir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01638",
                        "description": "Epoprostenol may decrease the excretion rate of Sorbitol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01656",
                        "description": "Epoprostenol may decrease the excretion rate of Roflumilast which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01685",
                        "description": "Epoprostenol may decrease the excretion rate of Topiroxostat which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB04871",
                        "description": "Epoprostenol may decrease the excretion rate of Lorcaserin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB04895",
                        "description": "Epoprostenol may decrease the excretion rate of Pegaptanib which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB04920",
                        "description": "Epoprostenol may decrease the excretion rate of Clevidipine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB04953",
                        "description": "Epoprostenol may decrease the excretion rate of Ezogabine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB05018",
                        "description": "Epoprostenol may decrease the excretion rate of Migalastat which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB05541",
                        "description": "Epoprostenol may decrease the excretion rate of Brivaracetam which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB05676",
                        "description": "Epoprostenol may decrease the excretion rate of Apremilast which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06154",
                        "description": "Epoprostenol may decrease the excretion rate of Pentaerythritol tetranitrate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06186",
                        "description": "Epoprostenol may decrease the excretion rate of Ipilimumab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06196",
                        "description": "Epoprostenol may decrease the excretion rate of Icatibant which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06203",
                        "description": "Epoprostenol may decrease the excretion rate of Alogliptin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06211",
                        "description": "Epoprostenol may decrease the excretion rate of Doripenem which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06230",
                        "description": "Epoprostenol may decrease the excretion rate of Nalmefene which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06262",
                        "description": "Epoprostenol may decrease the excretion rate of Droxidopa which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06282",
                        "description": "Epoprostenol may decrease the excretion rate of Levocetirizine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06335",
                        "description": "Epoprostenol may decrease the excretion rate of Saxagliptin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06402",
                        "description": "Epoprostenol may decrease the excretion rate of Telavancin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06480",
                        "description": "Epoprostenol may decrease the excretion rate of Prucalopride which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06623",
                        "description": "Epoprostenol may decrease the excretion rate of Flupirtine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06637",
                        "description": "Epoprostenol may decrease the excretion rate of Dalfampridine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06702",
                        "description": "Epoprostenol may decrease the excretion rate of Fesoterodine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06705",
                        "description": "Epoprostenol may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06710",
                        "description": "Epoprostenol may decrease the excretion rate of Methyltestosterone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06767",
                        "description": "Epoprostenol may decrease the excretion rate of Ammonium chloride which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06782",
                        "description": "Epoprostenol may decrease the excretion rate of Dimercaprol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06796",
                        "description": "Epoprostenol may decrease the excretion rate of Mangafodipir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06800",
                        "description": "Epoprostenol may decrease the excretion rate of Methylnaltrexone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06809",
                        "description": "Epoprostenol may decrease the excretion rate of Plerixafor which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06813",
                        "description": "Epoprostenol may decrease the excretion rate of Pralatrexate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06823",
                        "description": "Epoprostenol may decrease the excretion rate of Tiopronin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06824",
                        "description": "Epoprostenol may decrease the excretion rate of Triethylenetetramine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08824",
                        "description": "Epoprostenol may decrease the excretion rate of Ioflupane I 123 which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08826",
                        "description": "Epoprostenol may decrease the excretion rate of Deferiprone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08840",
                        "description": "Epoprostenol may decrease the excretion rate of N methylnicotinamide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08872",
                        "description": "Epoprostenol may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08877",
                        "description": "Epoprostenol may decrease the excretion rate of Ruxolitinib which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08893",
                        "description": "Epoprostenol may decrease the excretion rate of Mirabegron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08894",
                        "description": "Epoprostenol may decrease the excretion rate of Peginesatide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08897",
                        "description": "Epoprostenol may decrease the excretion rate of Aclidinium which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08899",
                        "description": "Epoprostenol may decrease the excretion rate of Enzalutamide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08900",
                        "description": "Epoprostenol may decrease the excretion rate of Teduglutide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08904",
                        "description": "Epoprostenol may decrease the excretion rate of Certolizumab pegol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08905",
                        "description": "Epoprostenol may decrease the excretion rate of Formestane which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08909",
                        "description": "Epoprostenol may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08910",
                        "description": "Epoprostenol may decrease the excretion rate of Pomalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08911",
                        "description": "Epoprostenol may decrease the excretion rate of Trametinib which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08934",
                        "description": "Epoprostenol may decrease the excretion rate of Sofosbuvir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09027",
                        "description": "Epoprostenol may decrease the excretion rate of Ledipasvir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09050",
                        "description": "Epoprostenol may decrease the excretion rate of Ceftolozane which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09066",
                        "description": "Epoprostenol may decrease the excretion rate of Corifollitropin alfa which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09068",
                        "description": "Epoprostenol may decrease the excretion rate of Vortioxetine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09071",
                        "description": "Epoprostenol may decrease the excretion rate of Tasimelteon which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09081",
                        "description": "Epoprostenol may decrease the excretion rate of Idebenone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09082",
                        "description": "Epoprostenol may decrease the excretion rate of Vilanterol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09089",
                        "description": "Epoprostenol may decrease the excretion rate of Trimebutine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09091",
                        "description": "Epoprostenol may decrease the excretion rate of Tixocortol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09103",
                        "description": "Epoprostenol may decrease the excretion rate of Ancestim which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09104",
                        "description": "Epoprostenol may decrease the excretion rate of Magnesium hydroxide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09106",
                        "description": "Epoprostenol may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09111",
                        "description": "Epoprostenol may decrease the excretion rate of Pentastarch which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09118",
                        "description": "Epoprostenol may decrease the excretion rate of Stiripentol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09121",
                        "description": "Epoprostenol may decrease the excretion rate of Aurothioglucose which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09129",
                        "description": "Epoprostenol may decrease the excretion rate of Chromic chloride which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09132",
                        "description": "Epoprostenol may decrease the excretion rate of Gadoteric acid which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09133",
                        "description": "Epoprostenol may decrease the excretion rate of Iothalamic acid which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09134",
                        "description": "Epoprostenol may decrease the excretion rate of Ioversol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09135",
                        "description": "Epoprostenol may decrease the excretion rate of Ioxilan which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09136",
                        "description": "Epoprostenol may decrease the excretion rate of Isosulfan blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09137",
                        "description": "Epoprostenol may decrease the excretion rate of Technetium Tc 99m mebrofenin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09139",
                        "description": "Epoprostenol may decrease the excretion rate of Technetium Tc 99m oxidronate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09148",
                        "description": "Epoprostenol may decrease the excretion rate of Florbetaben 18F which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09149",
                        "description": "Epoprostenol may decrease the excretion rate of Florbetapir 18F which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09156",
                        "description": "Epoprostenol may decrease the excretion rate of Iopromide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09163",
                        "description": "Epoprostenol may decrease the excretion rate of Technetium Tc 99m exametazime which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09165",
                        "description": "Epoprostenol may decrease the excretion rate of Technetium Tc 99m pyrophosphate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09185",
                        "description": "Epoprostenol may decrease the excretion rate of Viloxazine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09194",
                        "description": "Epoprostenol may decrease the excretion rate of Etoperidone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09195",
                        "description": "Epoprostenol may decrease the excretion rate of Lorpiprazole which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09204",
                        "description": "Epoprostenol may decrease the excretion rate of Arotinolol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09205",
                        "description": "Epoprostenol may decrease the excretion rate of Moxisylyte which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09209",
                        "description": "Epoprostenol may decrease the excretion rate of Pholcodine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09210",
                        "description": "Epoprostenol may decrease the excretion rate of Piracetam which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09219",
                        "description": "Epoprostenol may decrease the excretion rate of Bisoxatin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09223",
                        "description": "Epoprostenol may decrease the excretion rate of Blonanserin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09224",
                        "description": "Epoprostenol may decrease the excretion rate of Melperone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09256",
                        "description": "Epoprostenol may decrease the excretion rate of Tegafur which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09257",
                        "description": "Epoprostenol may decrease the excretion rate of Gimeracil which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09262",
                        "description": "Epoprostenol may decrease the excretion rate of Imidafenacin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09264",
                        "description": "Epoprostenol may decrease the excretion rate of Idarucizumab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09265",
                        "description": "Epoprostenol may decrease the excretion rate of Lixisenatide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09268",
                        "description": "Epoprostenol may decrease the excretion rate of Picosulfuric acid which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09276",
                        "description": "Epoprostenol may decrease the excretion rate of Sodium aurothiomalate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09277",
                        "description": "Epoprostenol may decrease the excretion rate of Choline C 11 which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09281",
                        "description": "Epoprostenol may decrease the excretion rate of Magnesium trisilicate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09292",
                        "description": "Epoprostenol may decrease the excretion rate of Sacubitril which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09301",
                        "description": "Epoprostenol may decrease the excretion rate of Chondroitin sulfate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09320",
                        "description": "Epoprostenol may decrease the excretion rate of Procaine benzylpenicillin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09324",
                        "description": "Epoprostenol may decrease the excretion rate of Sulbactam which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09325",
                        "description": "Epoprostenol may decrease the excretion rate of Sodium fluoride which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09344",
                        "description": "Epoprostenol may decrease the excretion rate of Invert sugar which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09357",
                        "description": "Epoprostenol may decrease the excretion rate of Dexpanthenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09394",
                        "description": "Epoprostenol may decrease the excretion rate of Phosphoric acid which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09395",
                        "description": "Epoprostenol may decrease the excretion rate of Sodium acetate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09407",
                        "description": "Epoprostenol may decrease the excretion rate of Magnesium chloride which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09472",
                        "description": "Epoprostenol may decrease the excretion rate of Sodium sulfate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09481",
                        "description": "Epoprostenol may decrease the excretion rate of Magnesium carbonate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09488",
                        "description": "Epoprostenol may decrease the excretion rate of Acrivastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09496",
                        "description": "Epoprostenol may decrease the excretion rate of Octinoxate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09502",
                        "description": "Epoprostenol may decrease the excretion rate of Fludeoxyglucose 18F which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09546",
                        "description": "Epoprostenol may decrease the excretion rate of Iobenguane sulfate I 123 which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09570",
                        "description": "Epoprostenol may decrease the excretion rate of Ixazomib which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11077",
                        "description": "Epoprostenol may decrease the excretion rate of Polyethylene glycol 400 which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11090",
                        "description": "Epoprostenol may decrease the excretion rate of Potassium nitrate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11098",
                        "description": "Epoprostenol may decrease the excretion rate of Potassium bicarbonate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11102",
                        "description": "Epoprostenol may decrease the excretion rate of N acetyltyrosine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11114",
                        "description": "Epoprostenol may decrease the excretion rate of Eucalyptus oil which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11127",
                        "description": "Epoprostenol may decrease the excretion rate of Selenious acid which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11130",
                        "description": "Epoprostenol may decrease the excretion rate of Opium which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11135",
                        "description": "Epoprostenol may decrease the excretion rate of Selenium which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11136",
                        "description": "Epoprostenol may decrease the excretion rate of Chromium which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11145",
                        "description": "Epoprostenol may decrease the excretion rate of Oxyquinoline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11156",
                        "description": "Epoprostenol may decrease the excretion rate of Pyrantel which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11164",
                        "description": "Epoprostenol may decrease the excretion rate of Bicisate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11251",
                        "description": "Epoprostenol may decrease the excretion rate of Tocopherol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11278",
                        "description": "Epoprostenol may decrease the excretion rate of DL Methylephedrine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11328",
                        "description": "Epoprostenol may decrease the excretion rate of Tetradecyl hydrogen sulfate ester which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11338",
                        "description": "Epoprostenol may decrease the excretion rate of Clove oil which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11358",
                        "description": "Epoprostenol may decrease the excretion rate of Evening primrose oil which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11364",
                        "description": "Epoprostenol may decrease the excretion rate of Pidotimod which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11560",
                        "description": "Epoprostenol may decrease the excretion rate of Lesinurad which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11577",
                        "description": "Epoprostenol may decrease the excretion rate of Indigotindisulfonic acid which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11587",
                        "description": "Epoprostenol may decrease the excretion rate of Etafedrine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11642",
                        "description": "Epoprostenol may decrease the excretion rate of Pitolisant which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11691",
                        "description": "Epoprostenol may decrease the excretion rate of Naldemedine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11699",
                        "description": "Epoprostenol may decrease the excretion rate of Tropisetron which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11817",
                        "description": "Epoprostenol may decrease the excretion rate of Baricitinib which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11901",
                        "description": "Epoprostenol may decrease the excretion rate of Apalutamide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11915",
                        "description": "Epoprostenol may decrease the excretion rate of Valbenazine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11943",
                        "description": "Epoprostenol may decrease the excretion rate of Delafloxacin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11989",
                        "description": "Epoprostenol may decrease the excretion rate of Benznidazole which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB12007",
                        "description": "Epoprostenol may decrease the excretion rate of Isoflavone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB12107",
                        "description": "Epoprostenol may decrease the excretion rate of Vaborbactam which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB12161",
                        "description": "Epoprostenol may decrease the excretion rate of Deutetrabenazine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB12278",
                        "description": "Epoprostenol may decrease the excretion rate of Propiverine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB12783",
                        "description": "Epoprostenol may decrease the excretion rate of Benserazide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13025",
                        "description": "Epoprostenol may decrease the excretion rate of Tiapride which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13139",
                        "description": "Epoprostenol may decrease the excretion rate of Levosalbutamol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13156",
                        "description": "Epoprostenol may decrease the excretion rate of Inosine pranobex which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13178",
                        "description": "Epoprostenol may decrease the excretion rate of Inositol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13185",
                        "description": "Epoprostenol may decrease the excretion rate of Oxabolone cipionate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13191",
                        "description": "Epoprostenol may decrease the excretion rate of Phosphocreatine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13269",
                        "description": "Epoprostenol may decrease the excretion rate of Dichlorobenzyl alcohol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13293",
                        "description": "Epoprostenol may decrease the excretion rate of Ipecac which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13595",
                        "description": "Epoprostenol may decrease the excretion rate of Almasilate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13873",
                        "description": "Epoprostenol may decrease the excretion rate of Fenofibric acid which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13909",
                        "description": "Epoprostenol may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13955",
                        "description": "Epoprostenol may decrease the excretion rate of Estradiol dienanthate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB14007",
                        "description": "Epoprostenol may decrease the excretion rate of Pentetic acid which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB14498",
                        "description": "Epoprostenol may decrease the excretion rate of Potassium acetate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB14499",
                        "description": "Epoprostenol may decrease the excretion rate of Potassium sulfate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB14526",
                        "description": "Epoprostenol may decrease the excretion rate of Chromic citrate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB14527",
                        "description": "Epoprostenol may decrease the excretion rate of Chromic nitrate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB14528",
                        "description": "Epoprostenol may decrease the excretion rate of Chromium gluconate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB14529",
                        "description": "Epoprostenol may decrease the excretion rate of Chromium nicotinate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB14530",
                        "description": "Epoprostenol may decrease the excretion rate of Chromous sulfate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB14754",
                        "description": "Epoprostenol may decrease the excretion rate of Solriamfetol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06815",
                        "description": "Epoprostenol may decrease the excretion rate of Pyrithione which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11121",
                        "description": "Epoprostenol may decrease the excretion rate of Chloroxylenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11085",
                        "description": "Epoprostenol may decrease the excretion rate of Resorcinol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB15593",
                        "description": "Epoprostenol may decrease the excretion rate of Golodirsen which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01115",
                        "description": "Nifedipine may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00321",
                        "description": "Amitriptyline may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00458",
                        "description": "Imipramine may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01142",
                        "description": "Doxepin may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00318",
                        "description": "Codeine may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00454",
                        "description": "Meperidine may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00879",
                        "description": "Emtricitabine may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB14506",
                        "description": "Epoprostenol may decrease the excretion rate of Lithium hydroxide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13987",
                        "description": "Epoprostenol may decrease the excretion rate of Strontium chloride which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB04890",
                        "description": "Epoprostenol may decrease the excretion rate of Bepotastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00982",
                        "description": "Isotretinoin may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB04930",
                        "description": "Epoprostenol may decrease the excretion rate of Permethrin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09095",
                        "description": "Epoprostenol may decrease the excretion rate of Difluocortolone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00479",
                        "description": "Amikacin may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00684",
                        "description": "Tobramycin may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00798",
                        "description": "Gentamicin may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00955",
                        "description": "Netilmicin may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00994",
                        "description": "Neomycin may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01082",
                        "description": "Streptomycin may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01172",
                        "description": "Kanamycin may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB03615",
                        "description": "Ribostamycin may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB04729",
                        "description": "Gentamicin C1a may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06696",
                        "description": "Arbekacin may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB12604",
                        "description": "Sisomicin may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13540",
                        "description": "Isepamicin may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00552",
                        "description": "Pentostatin may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13145",
                        "description": "Epoprostenol may decrease the excretion rate of Nedaplatin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00314",
                        "description": "Epoprostenol may decrease the excretion rate of Capreomycin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00512",
                        "description": "Epoprostenol may decrease the excretion rate of Vancomycin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00515",
                        "description": "Epoprostenol may decrease the excretion rate of Cisplatin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00564",
                        "description": "Epoprostenol may decrease the excretion rate of Carbamazepine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00642",
                        "description": "Epoprostenol may decrease the excretion rate of Pemetrexed which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01035",
                        "description": "Epoprostenol may decrease the excretion rate of Procainamide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB12615",
                        "description": "Epoprostenol may decrease the excretion rate of Plazomicin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB14509",
                        "description": "Epoprostenol may decrease the excretion rate of Lithium carbonate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00803",
                        "description": "Colistin may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00421",
                        "description": "Spironolactone may increase the excretion rate of Epoprostenol which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00594",
                        "description": "Amiloride may increase the excretion rate of Epoprostenol which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00703",
                        "description": "Methazolamide may increase the excretion rate of Epoprostenol which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00872",
                        "description": "Conivaptan may increase the excretion rate of Epoprostenol which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01144",
                        "description": "Diclofenamide may increase the excretion rate of Epoprostenol which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB06292",
                        "description": "Dapagliflozin may increase the excretion rate of Epoprostenol which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00695",
                        "description": "Furosemide may increase the excretion rate of Epoprostenol which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00887",
                        "description": "Bumetanide may increase the excretion rate of Epoprostenol which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00909",
                        "description": "Zonisamide may increase the excretion rate of Epoprostenol which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB08907",
                        "description": "Epoprostenol may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09338",
                        "description": "Epoprostenol may increase the excretion rate of Mersalyl which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00311",
                        "description": "Ethoxzolamide may increase the excretion rate of Epoprostenol which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00819",
                        "description": "Acetazolamide may increase the excretion rate of Epoprostenol which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01325",
                        "description": "Quinethazone may increase the excretion rate of Epoprostenol which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01412",
                        "description": "Theobromine may increase the excretion rate of Epoprostenol which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB02925",
                        "description": "Piretanide may increase the excretion rate of Epoprostenol which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB05034",
                        "description": "Ularitide may increase the excretion rate of Epoprostenol which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB06212",
                        "description": "Tolvaptan may increase the excretion rate of Epoprostenol which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB06370",
                        "description": "Indisulam may increase the excretion rate of Epoprostenol which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB08961",
                        "description": "Azosemide may increase the excretion rate of Epoprostenol which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09015",
                        "description": "Canrenoic acid may increase the excretion rate of Epoprostenol which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB11827",
                        "description": "Ertugliflozin may increase the excretion rate of Epoprostenol which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB12221",
                        "description": "Canrenone may increase the excretion rate of Epoprostenol which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB12670",
                        "description": "Rolofylline may increase the excretion rate of Epoprostenol which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB12704",
                        "description": "Spiradoline may increase the excretion rate of Epoprostenol which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB13284",
                        "description": "Meticrane may increase the excretion rate of Epoprostenol which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB13405",
                        "description": "Mefruside may increase the excretion rate of Epoprostenol which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB13617",
                        "description": "Clorexolone may increase the excretion rate of Epoprostenol which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB13663",
                        "description": "Clofenamide may increase the excretion rate of Epoprostenol which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB13708",
                        "description": "Fenquizone may increase the excretion rate of Epoprostenol which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB13792",
                        "description": "Clopamide may increase the excretion rate of Epoprostenol which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB13989",
                        "description": "Epitizide may increase the excretion rate of Epoprostenol which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB14018",
                        "description": "Bromotheophylline may increase the excretion rate of Epoprostenol which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB14500",
                        "description": "Potassium may increase the excretion rate of Epoprostenol which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01345",
                        "description": "Epoprostenol may increase the excretion rate of Potassium cation which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00182",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Amphetamine is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB11268",
                        "description": "The risk or severity of bleeding can be increased when Protocatechualdehyde is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00203",
                        "description": "The risk or severity of hemorrhage can be increased when Epoprostenol is combined with Sildenafil"
                    },
                    {
                        "drugbank-id": "DB00188",
                        "description": "The risk or severity of bleeding can be increased when Bortezomib is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB01041",
                        "description": "The risk or severity of bleeding can be increased when Thalidomide is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB01229",
                        "description": "The risk or severity of bleeding can be increased when Paclitaxel is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB09077",
                        "description": "The risk or severity of bleeding can be increased when Dinutuximab is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00181",
                        "description": "The risk or severity of adverse effects can be increased when Baclofen is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00671",
                        "description": "The therapeutic efficacy of Epoprostenol can be decreased when used in combination with Cefixime"
                    },
                    {
                        "drugbank-id": "DB14725",
                        "description": "The therapeutic efficacy of Epoprostenol can be decreased when used in combination with Cefamandole nafate"
                    },
                    {
                        "drugbank-id": "DB00190",
                        "description": "The risk or severity of hypotension can be increased when Carbidopa is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00254",
                        "description": "The risk or severity of bleeding can be increased when Doxycycline is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00207",
                        "description": "The risk or severity of adverse effects can be increased when Azithromycin is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00457",
                        "description": "The risk or severity of hypotension can be increased when Prazosin is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB09539",
                        "description": "The risk or severity of bleeding can be increased when Omega 3 acid ethyl esters is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00945",
                        "description": "Acetylsalicylic acid may increase the antiplatelet activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB01238",
                        "description": "The risk or severity of hypotension can be increased when Aripiprazole is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB14185",
                        "description": "The risk or severity of hypotension can be increased when Aripiprazole lauroxil is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00390",
                        "description": "The serum concentration of Digoxin can be increased when it is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB13401",
                        "description": "The serum concentration of Metildigoxin can be increased when it is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB13691",
                        "description": "The serum concentration of Acetyldigoxin can be increased when it is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB01050",
                        "description": "The risk or severity of bleeding can be increased when Ibuprofen is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB09213",
                        "description": "The risk or severity of bleeding can be increased when Dexibuprofen is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB01606",
                        "description": "The risk or severity of bleeding can be increased when Tazobactam is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00199",
                        "description": "The risk or severity of bleeding can be increased when Erythromycin is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00575",
                        "description": "The risk or severity of hypotension can be increased when Clonidine is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00656",
                        "description": "The risk or severity of bleeding can be increased when Trazodone is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00620",
                        "description": "The therapeutic efficacy of Epoprostenol can be decreased when used in combination with Triamcinolone"
                    },
                    {
                        "drugbank-id": "DB09079",
                        "description": "The risk or severity of bleeding can be increased when Epoprostenol is combined with Nintedanib"
                    },
                    {
                        "drugbank-id": "DB01175",
                        "description": "The risk or severity of bleeding can be increased when Escitalopram is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB01224",
                        "description": "Quetiapine may increase the hypotensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB01104",
                        "description": "The risk or severity of bleeding can be increased when Sertraline is combined with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB01020",
                        "description": "Isosorbide mononitrate may increase the vasodilatory activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00246",
                        "description": "Ziprasidone may increase the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00436",
                        "description": "The therapeutic efficacy of Bendroflumethiazide can be increased when used in combination with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00606",
                        "description": "The therapeutic efficacy of Cyclothiazide can be increased when used in combination with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00774",
                        "description": "The therapeutic efficacy of Hydroflumethiazide can be increased when used in combination with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00880",
                        "description": "The therapeutic efficacy of Chlorothiazide can be increased when used in combination with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00999",
                        "description": "The therapeutic efficacy of Hydrochlorothiazide can be increased when used in combination with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB01021",
                        "description": "The therapeutic efficacy of Trichlormethiazide can be increased when used in combination with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB01324",
                        "description": "The therapeutic efficacy of Polythiazide can be increased when used in combination with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB13532",
                        "description": "The therapeutic efficacy of Cyclopenthiazide can be increased when used in combination with Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB00232",
                        "description": "The therapeutic efficacy of Epoprostenol can be increased when used in combination with Methyclothiazide"
                    },
                    {
                        "drugbank-id": "DB00562",
                        "description": "The therapeutic efficacy of Epoprostenol can be increased when used in combination with Benzthiazide"
                    },
                    {
                        "drugbank-id": "DB13430",
                        "description": "The therapeutic efficacy of Epoprostenol can be increased when used in combination with Mebutizide"
                    },
                    {
                        "drugbank-id": "DB00808",
                        "description": "The therapeutic efficacy of Indapamide can be increased when used in combination with Epoprostenol"
                    }
                ]
            }
        },
        "revision_date": "2023-05-14"
    }
}